1  ||| S:21328 E:21330 ||| CD
cells ||| S:21330 E:21335 ||| NNS
,  ||| S:21335 E:21337 ||| ,
without  ||| S:21337 E:21345 ||| IN
constitutively  ||| S:21345 E:21360 ||| JJ
active  ||| S:21360 E:21375 ||| JJ
ERKs ||| S:21375 E:21379 ||| NN
,  ||| S:21379 E:21381 ||| ,
AA  ||| S:21381 E:21384 ||| NN
release  ||| S:21384 E:21392 ||| NN
is  ||| S:21392 E:21395 ||| VBZ
delayed  ||| S:21395 E:21403 ||| VBN
after  ||| S:21403 E:21409 ||| IN
[ ||| S:21409 E:21410 ||| -LRB-
Ca  ||| S:21410 E:21413 ||| NNP
2+ ||| S:21413 E:21415 ||| NNP
]  ||| S:21415 E:21426 ||| -RRB-
i  ||| S:21426 E:21428 ||| FW
mobilization ||| S:21428 E:21440 ||| FW
,  ||| S:21440 E:21442 ||| ,
and  ||| S:21442 E:21446 ||| CC
is  ||| S:21446 E:21449 ||| VBZ
temporally  ||| S:21449 E:21468 ||| JJ
correlated  ||| S:21468 E:21479 ||| NN
with  ||| S:21479 E:21484 ||| IN
ERK  ||| S:21484 E:21488 ||| NNP
activation  ||| S:21488 E:21499 ||| NNS
[  ||| S:21499 E:21501 ||| -LRB-
40  ||| S:21501 E:21504 ||| CD
]  ||| S:21504 E:21506 ||| -RRB-
,  ||| S:21506 E:21508 ||| ,
whereas  ||| S:21508 E:21516 ||| VBG
in  ||| S:21516 E:21519 ||| IN
MDCK  ||| S:21519 E:21532 ||| NNP
cells  ||| S:21532 E:21538 ||| NNS
with  ||| S:21538 E:21543 ||| IN
constitutively  ||| S:21543 E:21558 ||| JJ
active  ||| S:21558 E:21565 ||| JJ
ERKs ||| S:21565 E:21569 ||| NN
,  ||| S:21569 E:21571 ||| ,
AA  ||| S:21571 E:21574 ||| NN
release  ||| S:21574 E:21582 ||| NN
is  ||| S:21582 E:21585 ||| VBZ
rapid ||| S:21585 E:21590 ||| JJ
,  ||| S:21590 E:21600 ||| ,
with  ||| S:21600 E:21605 ||| IN
significant  ||| S:21605 E:21617 ||| JJ
AA  ||| S:21617 E:21620 ||| NN
release  ||| S:21620 E:21628 ||| NN
measured  ||| S:21628 E:21637 ||| VBD
30  ||| S:21637 E:21640 ||| CD
s  ||| S:21640 E:21642 ||| NN
after  ||| S:21642 E:21648 ||| IN
[ ||| S:21648 E:21649 ||| -LRB-
Ca  ||| S:21649 E:21652 ||| NNP
2+ ||| S:21652 E:21654 ||| NNP
]  ||| S:21654 E:21665 ||| -RRB-
i  ||| S:21665 E:21667 ||| FW
increase  ||| S:21667 E:21676 ||| NN
[  ||| S:21676 E:21678 ||| -LRB-
15  ||| S:21678 E:21681 ||| CD
]  ||| S:21681 E:21683 ||| -RRB-
.  ||| S:21683 E:21685 ||| .
This  ||| S:21685 E:21690 ||| DT
temporal  ||| S:21690 E:21707 ||| JJ
correlation  ||| S:21707 E:21719 ||| NN
between  ||| S:21719 E:21727 ||| IN
AA  ||| S:21727 E:21730 ||| NN
release  ||| S:21730 E:21738 ||| NN
and  ||| S:21738 E:21742 ||| CC
ERK  ||| S:21742 E:21746 ||| NNP
activation  ||| S:21746 E:21757 ||| NN
has  ||| S:21757 E:21761 ||| VBZ
also  ||| S:21761 E:21774 ||| RB
been  ||| S:21774 E:21779 ||| VBN
reported  ||| S:21779 E:21788 ||| VBN
in  ||| S:21788 E:21791 ||| IN
CHO  ||| S:21791 E:21795 ||| NNP
cells  ||| S:21795 E:21801 ||| NNS
in  ||| S:21801 E:21804 ||| IN
response  ||| S:21804 E:21813 ||| NN
to  ||| S:21813 E:21816 ||| TO
PAF  ||| S:21816 E:21820 ||| NNP
stimulation  ||| S:21820 E:21832 ||| NN
[  ||| S:21832 E:21842 ||| -LRB-
35  ||| S:21842 E:21845 ||| CD
41  ||| S:21845 E:21848 ||| CD
]  ||| S:21848 E:21850 ||| -RRB-
.  ||| S:21850 E:21852 ||| .
These  ||| S:21852 E:21858 ||| DT
results  ||| S:21858 E:21866 ||| NNS
support  ||| S:21866 E:21874 ||| VBP
the  ||| S:21874 E:21878 ||| DT
observations  ||| S:21878 E:21891 ||| NNS
made  ||| S:21891 E:21896 ||| VBD
here  ||| S:21896 E:21909 ||| RB
that  ||| S:21909 E:21914 ||| IN
ERK  ||| S:21914 E:21918 ||| NNP
activity  ||| S:21918 E:21927 ||| NN
is  ||| S:21927 E:21930 ||| VBZ
required  ||| S:21930 E:21939 ||| VBN
for  ||| S:21939 E:21943 ||| IN
phospholipid  ||| S:21943 E:21956 ||| JJ
hydrolysis  ||| S:21956 E:21975 ||| NNS
independently  ||| S:21975 E:21989 ||| RB
of  ||| S:21989 E:21992 ||| IN
cPLA  ||| S:21992 E:22006 ||| JJ
2  ||| S:22006 E:22008 ||| CD
translocation.  ||| S:22008 E:22031 ||| CD
cPLA  ||| S:22031 E:22045 ||| JJ
2  ||| S:22045 E:22047 ||| CD
-mediated  ||| S:22047 E:22057 ||| JJ
AA  ||| S:22057 E:22060 ||| NN
release  ||| S:22060 E:22068 ||| NN
must  ||| S:22068 E:22073 ||| MD
be  ||| S:22073 E:22076 ||| VB
preceded  ||| S:22076 E:22093 ||| VBN
by  ||| S:22093 E:22096 ||| IN
translocation  ||| S:22096 E:22110 ||| NN
of  ||| S:22110 E:22113 ||| IN
the  ||| S:22113 E:22117 ||| DT
enzyme  ||| S:22117 E:22124 ||| NN
to  ||| S:22124 E:22127 ||| TO
its  ||| S:22127 E:22131 ||| PRP$
membrane  ||| S:22131 E:22140 ||| JJ
substrate  ||| S:22140 E:22158 ||| NN
which  ||| S:22158 E:22164 ||| WDT
is  ||| S:22164 E:22167 ||| VBZ
a  ||| S:22167 E:22169 ||| DT
Ca  ||| S:22169 E:22172 ||| NNP
2+-dependent  ||| S:22172 E:22185 ||| NNP
process  ||| S:22185 E:22193 ||| NN
and  ||| S:22193 E:22197 ||| CC
is  ||| S:22197 E:22200 ||| VBZ
a  ||| S:22200 E:22202 ||| DT
function  ||| S:22202 E:22211 ||| NN
of  ||| S:22211 E:22214 ||| IN
the  ||| S:22214 E:22226 ||| DT
calcium-dependent  ||| S:22226 E:22244 ||| JJ
lipid-binding  ||| S:22244 E:22258 ||| NN
( ||| S:22258 E:22259 ||| -LRB-
C2 ||| S:22259 E:22261 ||| NNP
)  ||| S:22261 E:22263 ||| -RRB-
domain.  ||| S:22263 E:22271 ||| NNP
cPLA  ||| S:22271 E:22285 ||| NNP
2  ||| S:22285 E:22287 ||| CD
translocates  ||| S:22287 E:22300 ||| NNS
primarily  ||| S:22300 E:22310 ||| RB
to  ||| S:22310 E:22313 ||| TO
Golgi  ||| S:22313 E:22319 ||| NNP
in  ||| S:22319 E:22330 ||| IN
response  ||| S:22330 E:22339 ||| NN
to  ||| S:22339 E:22342 ||| TO
a  ||| S:22342 E:22344 ||| DT
transient  ||| S:22344 E:22354 ||| NN
[ ||| S:22354 E:22355 ||| -LRB-
Ca  ||| S:22355 E:22358 ||| NNP
2+ ||| S:22358 E:22360 ||| NNP
]  ||| S:22360 E:22371 ||| -RRB-
i  ||| S:22371 E:22373 ||| FW
changes  ||| S:22373 E:22381 ||| NNS
and  ||| S:22381 E:22385 ||| CC
to  ||| S:22385 E:22388 ||| TO
Golgi  ||| S:22388 E:22394 ||| NNP
and  ||| S:22394 E:22398 ||| CC
ER  ||| S:22398 E:22401 ||| NNP
in  ||| S:22401 E:22412 ||| IN
response  ||| S:22412 E:22421 ||| NN
to  ||| S:22421 E:22424 ||| TO
a  ||| S:22424 E:22426 ||| DT
sustained  ||| S:22426 E:22436 ||| JJ
[ ||| S:22436 E:22437 ||| -LRB-
Ca  ||| S:22437 E:22440 ||| NNP
2+ ||| S:22440 E:22442 ||| NNP
]  ||| S:22442 E:22453 ||| -RRB-
i  ||| S:22453 E:22455 ||| FW
increase  ||| S:22455 E:22464 ||| NN
[  ||| S:22464 E:22466 ||| -LRB-
15  ||| S:22466 E:22469 ||| CD
]  ||| S:22469 E:22471 ||| -RRB-
.  ||| S:22471 E:22473 ||| .
The  ||| S:22473 E:22477 ||| DT
reduction  ||| S:22477 E:22487 ||| NN
in  ||| S:22487 E:22490 ||| IN
AA  ||| S:22490 E:22501 ||| NN
release  ||| S:22501 E:22509 ||| NN
by  ||| S:22509 E:22512 ||| IN
MEK  ||| S:22512 E:22516 ||| NNP
inhibition  ||| S:22516 E:22527 ||| NN
did  ||| S:22527 E:22531 ||| VBD
not  ||| S:22531 E:22535 ||| RB
involve  ||| S:22535 E:22543 ||| VB
a  ||| S:22543 E:22545 ||| DT
failure  ||| S:22545 E:22553 ||| NN
in  ||| S:22553 E:22556 ||| IN
[ ||| S:22556 E:22557 ||| -LRB-
Ca  ||| S:22557 E:22568 ||| NNP
2+ ||| S:22568 E:22570 ||| NNP
]  ||| S:22570 E:22581 ||| -RRB-
i  ||| S:22581 E:22583 ||| FW
release  ||| S:22583 E:22591 ||| NN
or  ||| S:22591 E:22594 ||| CC
translocation ||| S:22594 E:22607 ||| NN
.  ||| S:22607 E:22609 ||| .
These  ||| S:22609 E:22623 ||| DT
results  ||| S:22623 E:22631 ||| NNS
show  ||| S:22631 E:22636 ||| VBP
that  ||| S:22636 E:22641 ||| DT
translocation  ||| S:22641 E:22655 ||| NN
is  ||| S:22655 E:22658 ||| VBZ
necessary  ||| S:22658 E:22668 ||| JJ
but  ||| S:22668 E:22672 ||| CC
not  ||| S:22672 E:22684 ||| RB
sufficient  ||| S:22684 E:22695 ||| JJ
for  ||| S:22695 E:22699 ||| IN
optimum  ||| S:22699 E:22707 ||| JJ
hydrolytic  ||| S:22707 E:22718 ||| JJ
activity ||| S:22718 E:22726 ||| NN
.  ||| S:22726 E:22736 ||| .
Measuring  ||| S:22736 E:22746 ||| VBG
cPLA  ||| S:22746 E:22760 ||| JJ
2  ||| S:22760 E:22762 ||| CD
translocation  ||| S:22762 E:22776 ||| NN
is  ||| S:22776 E:22779 ||| VBZ
not  ||| S:22779 E:22783 ||| RB
a  ||| S:22783 E:22785 ||| DT
trivial  ||| S:22785 E:22793 ||| JJ
matter  ||| S:22793 E:22808 ||| NN
when  ||| S:22808 E:22813 ||| WRB
investigating  ||| S:22813 E:22827 ||| VBG
mechanisms  ||| S:22827 E:22838 ||| NNS
of  ||| S:22838 E:22841 ||| IN
AA  ||| S:22841 E:22844 ||| NN
release ||| S:22844 E:22851 ||| NN
.  ||| S:22851 E:22853 ||| .
For  ||| S:22853 E:22857 ||| IN
example ||| S:22857 E:22864 ||| NN
,  ||| S:22864 E:22874 ||| ,
cPLA  ||| S:22874 E:22888 ||| JJ
2  ||| S:22888 E:22890 ||| CD
constructs  ||| S:22890 E:22901 ||| NN
with  ||| S:22901 E:22906 ||| IN
a  ||| S:22906 E:22908 ||| DT
S505A  ||| S:22908 E:22914 ||| CD
mutation  ||| S:22914 E:22923 ||| NNS
have  ||| S:22923 E:22936 ||| VBP
long  ||| S:22936 E:22941 ||| RB
been  ||| S:22941 E:22946 ||| VBN
recognized  ||| S:22946 E:22957 ||| VBN
as  ||| S:22957 E:22960 ||| IN
unable  ||| S:22960 E:22967 ||| JJ
to  ||| S:22967 E:22970 ||| TO
support  ||| S:22970 E:22978 ||| VB
AA  ||| S:22978 E:22981 ||| NN
release  ||| S:22981 E:22989 ||| NN
in  ||| S:22989 E:23000 ||| IN
response  ||| S:23000 E:23009 ||| NN
to  ||| S:23009 E:23012 ||| TO
physiological  ||| S:23012 E:23026 ||| VB
agonists  ||| S:23026 E:23035 ||| NNS
or  ||| S:23035 E:23038 ||| CC
low-dose  ||| S:23038 E:23047 ||| JJ
ionophore  ||| S:23047 E:23065 ||| NN
when  ||| S:23065 E:23070 ||| WRB
transfected  ||| S:23070 E:23082 ||| NNS
in  ||| S:23082 E:23085 ||| IN
cells ||| S:23085 E:23090 ||| NNS
.  ||| S:23090 E:23092 ||| .
In  ||| S:23092 E:23095 ||| IN
contrast ||| S:23095 E:23103 ||| NN
,  ||| S:23103 E:23105 ||| ,
cPLA  ||| S:23105 E:23119 ||| JJ
2  ||| S:23119 E:23121 ||| CD
S505A  ||| S:23121 E:23127 ||| CD
is  ||| S:23127 E:23130 ||| VBZ
active  ||| S:23130 E:23137 ||| JJ
in  ||| S:23137 E:23140 ||| IN
vitro  ||| S:23140 E:23146 ||| NN
and  ||| S:23146 E:23158 ||| CC
phosphorylation  ||| S:23158 E:23174 ||| VBP
only  ||| S:23174 E:23179 ||| RB
modestly  ||| S:23179 E:23188 ||| RB
increases  ||| S:23188 E:23198 ||| VBZ
the  ||| S:23198 E:23202 ||| DT
activity  ||| S:23202 E:23211 ||| NN
of  ||| S:23211 E:23214 ||| IN
the  ||| S:23214 E:23226 ||| DT
enzyme  ||| S:23226 E:23233 ||| NN
[  ||| S:23233 E:23235 ||| -LRB-
16  ||| S:23235 E:23238 ||| CD
17  ||| S:23238 E:23241 ||| CD
24  ||| S:23241 E:23244 ||| CD
]  ||| S:23244 E:23246 ||| -RRB-
.  ||| S:23246 E:23248 ||| .
Interestingly ||| S:23248 E:23261 ||| RB
,  ||| S:23261 E:23263 ||| ,
the  ||| S:23263 E:23267 ||| DT
inhibitory  ||| S:23267 E:23278 ||| JJ
effect  ||| S:23278 E:23293 ||| NN
of  ||| S:23293 E:23296 ||| IN
the  ||| S:23296 E:23300 ||| DT
S505A  ||| S:23300 E:23306 ||| JJ
mutation  ||| S:23306 E:23315 ||| NN
on  ||| S:23315 E:23318 ||| IN
AA  ||| S:23318 E:23321 ||| NN
release  ||| S:23321 E:23329 ||| NN
is  ||| S:23329 E:23332 ||| VBZ
obviated  ||| S:23332 E:23341 ||| VBN
by  ||| S:23341 E:23344 ||| IN
a  ||| S:23344 E:23346 ||| DT
high  ||| S:23346 E:23359 ||| JJ
[ ||| S:23359 E:23360 ||| -LRB-
Ca  ||| S:23360 E:23363 ||| NNP
2+ ||| S:23363 E:23365 ||| NNP
]  ||| S:23365 E:23376 ||| -RRB-
i  ||| S:23376 E:23378 ||| FW
increase ||| S:23378 E:23386 ||| NN
.  ||| S:23386 E:23388 ||| .
In  ||| S:23388 E:23391 ||| IN
light  ||| S:23391 E:23397 ||| NN
of  ||| S:23397 E:23400 ||| IN
these  ||| S:23400 E:23414 ||| DT
observations ||| S:23414 E:23426 ||| NNS
,  ||| S:23426 E:23428 ||| ,
it  ||| S:23428 E:23431 ||| PRP
is  ||| S:23431 E:23434 ||| VBZ
possible  ||| S:23434 E:23443 ||| JJ
that  ||| S:23443 E:23448 ||| IN
Ser  ||| S:23448 E:23452 ||| NNP
505phosphorylation  ||| S:23452 E:23479 ||| NNP
may  ||| S:23479 E:23483 ||| MD
alter  ||| S:23483 E:23489 ||| VB
the  ||| S:23489 E:23493 ||| DT
[ ||| S:23493 E:23494 ||| -LRB-
Ca  ||| S:23494 E:23497 ||| NNP
2+ ||| S:23497 E:23499 ||| NNP
]  ||| S:23499 E:23510 ||| -RRB-
i  ||| S:23510 E:23512 ||| FW
sensitivity  ||| S:23512 E:23524 ||| FW
of  ||| S:23524 E:23527 ||| IN
the  ||| S:23527 E:23531 ||| DT
enzyme ||| S:23531 E:23537 ||| NN
,  ||| S:23537 E:23539 ||| ,
its  ||| S:23539 E:23543 ||| PRP$
rate  ||| S:23543 E:23548 ||| NN
of  ||| S:23548 E:23559 ||| IN
translocation ||| S:23559 E:23572 ||| NN
,  ||| S:23572 E:23574 ||| ,
its  ||| S:23574 E:23578 ||| PRP$
intracellular  ||| S:23578 E:23592 ||| JJ
targeting  ||| S:23592 E:23602 ||| NN
or ||| S:23602 E:23604 ||| CC
,  ||| S:23604 E:23606 ||| ,
as  ||| S:23606 E:23609 ||| RB
has  ||| S:23609 E:23613 ||| VBZ
been  ||| S:23613 E:23626 ||| VBN
previously  ||| S:23626 E:23637 ||| RB
suggested  ||| S:23637 E:23647 ||| VBD
[  ||| S:23647 E:23649 ||| -LRB-
22  ||| S:23649 E:23652 ||| CD
]  ||| S:23652 E:23654 ||| -RRB-
,  ||| S:23654 E:23656 ||| ,
the  ||| S:23656 E:23660 ||| DT
ability  ||| S:23660 E:23668 ||| NN
of  ||| S:23668 E:23671 ||| IN
cPLA  ||| S:23671 E:23685 ||| JJ
2  ||| S:23685 E:23687 ||| CD
to  ||| S:23687 E:23690 ||| TO
release  ||| S:23690 E:23698 ||| VB
from  ||| S:23698 E:23703 ||| IN
a  ||| S:23703 E:23705 ||| DT
non-membrane  ||| S:23705 E:23726 ||| JJ
sequestering  ||| S:23726 E:23739 ||| JJ
agent ||| S:23739 E:23744 ||| NN
.  ||| S:23744 E:23746 ||| .
Although  ||| S:23746 E:23755 ||| IN
one  ||| S:23755 E:23759 ||| CD
report  ||| S:23759 E:23766 ||| NN
has  ||| S:23766 E:23770 ||| VBZ
shown  ||| S:23770 E:23776 ||| VBN
that  ||| S:23776 E:23781 ||| IN
cPLA  ||| S:23781 E:23803 ||| JJ
2  ||| S:23803 E:23805 ||| CD
S505A  ||| S:23805 E:23811 ||| CD
translocates  ||| S:23811 E:23824 ||| NN
in  ||| S:23824 E:23827 ||| IN
CHO  ||| S:23827 E:23831 ||| NNP
cells  ||| S:23831 E:23837 ||| NNS
in  ||| S:23837 E:23848 ||| IN
response  ||| S:23848 E:23857 ||| NN
to  ||| S:23857 E:23860 ||| TO
ionophore ||| S:23860 E:23869 ||| VB
,  ||| S:23869 E:23871 ||| ,
we  ||| S:23871 E:23874 ||| PRP
were  ||| S:23874 E:23879 ||| VBD
able  ||| S:23879 E:23884 ||| JJ
to  ||| S:23884 E:23887 ||| TO
directly  ||| S:23887 E:23896 ||| RB
compare  ||| S:23896 E:23912 ||| VB
rates  ||| S:23912 E:23918 ||| NNS
of  ||| S:23918 E:23921 ||| IN
translocation  ||| S:23921 E:23935 ||| NN
between  ||| S:23935 E:23943 ||| IN
cPLA  ||| S:23943 E:23957 ||| JJ
2  ||| S:23957 E:23959 ||| CD
and  ||| S:23959 E:23963 ||| CC
cPLA  ||| S:23963 E:23977 ||| JJ
2  ||| S:23977 E:23979 ||| CD
S505A  ||| S:23979 E:23985 ||| CD
to  ||| S:23985 E:23988 ||| TO
a  ||| S:23988 E:23990 ||| DT
physiological  ||| S:23990 E:24004 ||| JJ
agonist  ||| S:24004 E:24012 ||| NN
and  ||| S:24012 E:24024 ||| CC
found  ||| S:24024 E:24030 ||| VBD
no  ||| S:24030 E:24033 ||| DT
difference  ||| S:24033 E:24044 ||| NN
between  ||| S:24044 E:24052 ||| IN
translocation  ||| S:24052 E:24066 ||| JJ
rates  ||| S:24066 E:24072 ||| NNS
or  ||| S:24072 E:24083 ||| CC
intracellular  ||| S:24083 E:24097 ||| JJ
targeting ||| S:24097 E:24106 ||| NN
.  ||| S:24106 E:24108 ||| .
We  ||| S:24108 E:24111 ||| PRP
also  ||| S:24111 E:24116 ||| RB
demonstrated  ||| S:24116 E:24129 ||| VBN
that  ||| S:24129 E:24134 ||| IN
there  ||| S:24134 E:24148 ||| EX
was  ||| S:24148 E:24152 ||| VBD
no  ||| S:24152 E:24155 ||| DT
difference  ||| S:24155 E:24166 ||| NN
in  ||| S:24166 E:24169 ||| IN
translocation  ||| S:24169 E:24183 ||| JJ
rates  ||| S:24183 E:24189 ||| NNS
or  ||| S:24189 E:24192 ||| CC
intracellular  ||| S:24192 E:24214 ||| VBP
targeting  ||| S:24214 E:24224 ||| VBG
between  ||| S:24224 E:24232 ||| IN
wild-type  ||| S:24232 E:24242 ||| JJ
cPLA  ||| S:24242 E:24256 ||| JJ
2  ||| S:24256 E:24258 ||| CD
and  ||| S:24258 E:24262 ||| CC
cPLA  ||| S:24262 E:24276 ||| JJ
2  ||| S:24276 E:24278 ||| CD
S727A ||| S:24278 E:24283 ||| CD
,  ||| S:24283 E:24285 ||| ,
which  ||| S:24285 E:24291 ||| WDT
has  ||| S:24291 E:24295 ||| VBZ
the  ||| S:24295 E:24299 ||| DT
same  ||| S:24299 E:24304 ||| JJ
phenotype  ||| S:24304 E:24314 ||| NN
as  ||| S:24314 E:24325 ||| IN
S505A  ||| S:24325 E:24331 ||| CD
with  ||| S:24331 E:24336 ||| IN
regard  ||| S:24336 E:24343 ||| NN
to  ||| S:24343 E:24346 ||| TO
AA  ||| S:24346 E:24349 ||| NN
release  ||| S:24349 E:24357 ||| NN
when  ||| S:24357 E:24362 ||| WRB
transfected  ||| S:24362 E:24374 ||| NNS
into  ||| S:24374 E:24387 ||| IN
cells ||| S:24387 E:24392 ||| NNS
.  ||| S:24392 E:24394 ||| .
Thus ||| S:24394 E:24398 ||| RB
,  ||| S:24398 E:24400 ||| ,
the  ||| S:24400 E:24404 ||| DT
role  ||| S:24404 E:24409 ||| NN
of  ||| S:24409 E:24412 ||| IN
cPLA  ||| S:24412 E:24426 ||| JJ
2  ||| S:24426 E:24428 ||| CD
phosphorylation  ||| S:24428 E:24444 ||| NN
in  ||| S:24444 E:24447 ||| IN
mediating  ||| S:24447 E:24457 ||| JJ
AA  ||| S:24457 E:24468 ||| NN
release  ||| S:24468 E:24476 ||| NN
remains  ||| S:24476 E:24484 ||| VBZ
unclear ||| S:24484 E:24491 ||| JJ
.  ||| S:24491 E:24501 ||| .
Although  ||| S:24501 E:24510 ||| IN
the  ||| S:24510 E:24514 ||| DT
alternative  ||| S:24514 E:24526 ||| JJ
mechanism  ||| S:24526 E:24536 ||| NN
whereby  ||| S:24536 E:24544 ||| WRB
the  ||| S:24544 E:24548 ||| DT
MEK1 ||| S:24548 E:24552 ||| NNP
/ ||| S:24552 E:24553 ||| NNP
ERK  ||| S:24553 E:24565 ||| NNP
pathway  ||| S:24565 E:24573 ||| NN
regulates  ||| S:24573 E:24583 ||| VBZ
cPLA  ||| S:24583 E:24597 ||| JJ
2  ||| S:24597 E:24599 ||| CD
is  ||| S:24599 E:24602 ||| VBZ
not  ||| S:24602 E:24606 ||| RB
known ||| S:24606 E:24611 ||| VBN
,  ||| S:24611 E:24613 ||| ,
it  ||| S:24613 E:24616 ||| PRP
is  ||| S:24616 E:24619 ||| VBZ
possible  ||| S:24619 E:24628 ||| JJ
that  ||| S:24628 E:24633 ||| IN
it  ||| S:24633 E:24644 ||| PRP
affects  ||| S:24644 E:24652 ||| VBZ
membrane  ||| S:24652 E:24661 ||| JJ
properties  ||| S:24661 E:24672 ||| NNS
and ||| S:24672 E:24675 ||| CC
/ ||| S:24675 E:24676 ||| NNP
or  ||| S:24676 E:24679 ||| CC
cPLA  ||| S:24679 E:24693 ||| JJ
2  ||| S:24693 E:24695 ||| CD
conformation  ||| S:24695 E:24708 ||| NNS
that  ||| S:24708 E:24713 ||| WDT
promotes  ||| S:24713 E:24722 ||| VBZ
optimal  ||| S:24722 E:24738 ||| JJ
hydrolytic  ||| S:24738 E:24749 ||| JJ
activity ||| S:24749 E:24757 ||| NN
.  ||| S:24757 E:24759 ||| .
It  ||| S:24759 E:24762 ||| PRP
is  ||| S:24762 E:24765 ||| VBZ
also  ||| S:24765 E:24770 ||| RB
possible  ||| S:24770 E:24779 ||| JJ
that  ||| S:24779 E:24784 ||| IN
the  ||| S:24784 E:24796 ||| DT
alternative  ||| S:24796 E:24808 ||| JJ
mechanism  ||| S:24808 E:24818 ||| NN
is  ||| S:24818 E:24821 ||| VBZ
due  ||| S:24821 E:24825 ||| JJ
to  ||| S:24825 E:24828 ||| TO
phosphorylation  ||| S:24828 E:24844 ||| VB
of  ||| S:24844 E:24847 ||| IN
cPLA  ||| S:24847 E:24861 ||| JJ
2  ||| S:24861 E:24863 ||| CD
on  ||| S:24863 E:24866 ||| IN
a  ||| S:24866 E:24868 ||| DT
novel  ||| S:24868 E:24874 ||| NN
site  ||| S:24874 E:24879 ||| NN
by  ||| S:24879 E:24882 ||| IN
a  ||| S:24882 E:24884 ||| DT
kinase  ||| S:24884 E:24891 ||| NN
that  ||| S:24891 E:24896 ||| WDT
is  ||| S:24896 E:24907 ||| VBZ
downstream  ||| S:24907 E:24918 ||| VBN
of  ||| S:24918 E:24921 ||| IN
the  ||| S:24921 E:24925 ||| DT
MEK1 ||| S:24925 E:24929 ||| NNP
/ ||| S:24929 E:24930 ||| NNP
ERK  ||| S:24930 E:24934 ||| NNP
pathway  ||| S:24934 E:24942 ||| NN
or  ||| S:24942 E:24945 ||| CC
phosphorylation  ||| S:24945 E:24961 ||| NN
of  ||| S:24961 E:24964 ||| IN
a  ||| S:24964 E:24974 ||| DT
regulatory  ||| S:24974 E:24985 ||| JJ
protein ||| S:24985 E:24992 ||| NN
.  ||| S:24992 E:25016 ||| .
Conclusions  ||| S:25016 E:25036 ||| NNP
Translocation  ||| S:25036 E:25050 ||| NNP
to  ||| S:25050 E:25053 ||| TO
membrane  ||| S:25053 E:25062 ||| NN
is  ||| S:25062 E:25065 ||| VBZ
a  ||| S:25065 E:25067 ||| DT
critical  ||| S:25067 E:25076 ||| JJ
regulatory  ||| S:25076 E:25087 ||| JJ
step  ||| S:25087 E:25100 ||| NN
for  ||| S:25100 E:25104 ||| IN
the  ||| S:25104 E:25108 ||| DT
action  ||| S:25108 E:25115 ||| NN
of  ||| S:25115 E:25118 ||| IN
cPLA  ||| S:25118 E:25132 ||| JJ
2  ||| S:25132 E:25134 ||| CD
because  ||| S:25134 E:25142 ||| IN
it  ||| S:25142 E:25145 ||| PRP
is  ||| S:25145 E:25148 ||| VBZ
necessary  ||| S:25148 E:25158 ||| JJ
for  ||| S:25158 E:25162 ||| IN
access  ||| S:25162 E:25169 ||| NN
to  ||| S:25169 E:25180 ||| TO
substrate ||| S:25180 E:25189 ||| VB
.  ||| S:25189 E:25191 ||| .
In  ||| S:25191 E:25194 ||| IN
this  ||| S:25194 E:25199 ||| DT
study  ||| S:25199 E:25205 ||| NN
we  ||| S:25205 E:25208 ||| PRP
demonstrate ||| S:25208 E:25219 ||| VBP
,  ||| S:25219 E:25221 ||| ,
however ||| S:25221 E:25228 ||| RB
,  ||| S:25228 E:25230 ||| ,
that  ||| S:25230 E:25243 ||| DT
association  ||| S:25243 E:25255 ||| NN
of  ||| S:25255 E:25258 ||| IN
cPLA  ||| S:25258 E:25272 ||| JJ
2  ||| S:25272 E:25274 ||| CD
with  ||| S:25274 E:25279 ||| IN
membrane  ||| S:25279 E:25288 ||| NN
when  ||| S:25288 E:25293 ||| WRB
phosphorylated  ||| S:25293 E:25308 ||| NNS
on  ||| S:25308 E:25319 ||| IN
Ser  ||| S:25319 E:25323 ||| NNP
505is  ||| S:25323 E:25329 ||| NNP
not  ||| S:25329 E:25333 ||| RB
sufficient  ||| S:25333 E:25344 ||| JJ
for  ||| S:25344 E:25348 ||| IN
its  ||| S:25348 E:25352 ||| PRP$
full  ||| S:25352 E:25357 ||| JJ
activity  ||| S:25357 E:25366 ||| NN
in  ||| S:25366 E:25369 ||| IN
vivo ||| S:25369 E:25373 ||| NN
.  ||| S:25373 E:25383 ||| .
This  ||| S:25383 E:25388 ||| DT
is  ||| S:25388 E:25391 ||| VBZ
demonstrated  ||| S:25391 E:25404 ||| VBN
by  ||| S:25404 E:25407 ||| IN
the  ||| S:25407 E:25411 ||| DT
results  ||| S:25411 E:25419 ||| NNS
showing  ||| S:25419 E:25427 ||| VBG
that  ||| S:25427 E:25432 ||| DT
inhibition  ||| S:25432 E:25451 ||| NN
of  ||| S:25451 E:25454 ||| IN
the  ||| S:25454 E:25458 ||| DT
MEK1 ||| S:25458 E:25462 ||| NNP
/ ||| S:25462 E:25463 ||| NNP
ERK  ||| S:25463 E:25467 ||| NNP
pathway  ||| S:25467 E:25475 ||| VBD
significantly  ||| S:25475 E:25489 ||| RB
blocks  ||| S:25489 E:25496 ||| JJ
AA  ||| S:25496 E:25499 ||| NN
release  ||| S:25499 E:25507 ||| NN
but  ||| S:25507 E:25519 ||| CC
has  ||| S:25519 E:25523 ||| VBZ
no  ||| S:25523 E:25526 ||| DT
effect  ||| S:25526 E:25533 ||| NN
on  ||| S:25533 E:25536 ||| IN
[ ||| S:25536 E:25537 ||| -LRB-
Ca  ||| S:25537 E:25540 ||| NNP
2+ ||| S:25540 E:25542 ||| NNP
]  ||| S:25542 E:25553 ||| -RRB-
i  ||| S:25553 E:25555 ||| FW
mobilization  ||| S:25555 E:25568 ||| FW
or  ||| S:25568 E:25571 ||| CC
cPLA  ||| S:25571 E:25585 ||| JJ
2  ||| S:25585 E:25587 ||| CD
translocation  ||| S:25587 E:25601 ||| NNS
and  ||| S:25601 E:25605 ||| CC
targeting ||| S:25605 E:25614 ||| VBG
.  ||| S:25614 E:25624 ||| .
Diminution  ||| S:25624 E:25635 ||| NNP
of  ||| S:25635 E:25638 ||| IN
AA  ||| S:25638 E:25641 ||| NN
release  ||| S:25641 E:25649 ||| NN
by  ||| S:25649 E:25652 ||| IN
MEK1 ||| S:25652 E:25656 ||| NNP
/ ||| S:25656 E:25657 ||| NNP
ERK  ||| S:25657 E:25661 ||| NNP
is  ||| S:25661 E:25664 ||| VBZ
also  ||| S:25664 E:25669 ||| RB
independent  ||| S:25669 E:25681 ||| JJ
of  ||| S:25681 E:25692 ||| IN
cPLA  ||| S:25692 E:25706 ||| JJ
2  ||| S:25706 E:25708 ||| CD
phosphorylation  ||| S:25708 E:25724 ||| NN
on  ||| S:25724 E:25727 ||| IN
Ser  ||| S:25727 E:25731 ||| NNP
505 ||| S:25731 E:25734 ||| CD
.  ||| S:25734 E:25744 ||| .
Consequently ||| S:25744 E:25756 ||| RB
,  ||| S:25756 E:25758 ||| ,
our  ||| S:25758 E:25762 ||| PRP$
results  ||| S:25762 E:25770 ||| NNS
demonstrate  ||| S:25770 E:25782 ||| VBP
in  ||| S:25782 E:25785 ||| IN
living  ||| S:25785 E:25792 ||| VBG
cells  ||| S:25792 E:25798 ||| NNS
that  ||| S:25798 E:25811 ||| IN
the  ||| S:25811 E:25815 ||| DT
translocation  ||| S:25815 E:25829 ||| JJ
process  ||| S:25829 E:25837 ||| NN
and  ||| S:25837 E:25841 ||| CC
subsequent  ||| S:25841 E:25852 ||| JJ
catalytic  ||| S:25852 E:25862 ||| JJ
activity  ||| S:25862 E:25879 ||| NN
on  ||| S:25879 E:25882 ||| IN
the  ||| S:25882 E:25886 ||| DT
membrane  ||| S:25886 E:25895 ||| NNS
are  ||| S:25895 E:25899 ||| VBP
two  ||| S:25899 E:25903 ||| CD
independently  ||| S:25903 E:25917 ||| RB
regulated  ||| S:25917 E:25927 ||| VBN
steps ||| S:25927 E:25932 ||| NNS
.  ||| S:25932 E:25956 ||| .
Materials  ||| S:25956 E:25966 ||| NNS
and  ||| S:25966 E:25970 ||| CC
Methods  ||| S:25970 E:25997 ||| NNP
Fluorescent  ||| S:25997 E:26009 ||| NNP
protein-cPLA  ||| S:26009 E:26022 ||| NNP
2fusion  ||| S:26022 E:26030 ||| NNP
constructs  ||| S:26030 E:26051 ||| VBD
DNA  ||| S:26051 E:26055 ||| NNP
encoding  ||| S:26055 E:26064 ||| VBD
the  ||| S:26064 E:26068 ||| DT
full-length  ||| S:26068 E:26080 ||| JJ
human  ||| S:26080 E:26086 ||| JJ
cPLA  ||| S:26086 E:26102 ||| JJ
2  ||| S:26102 E:26104 ||| CD
was  ||| S:26104 E:26108 ||| VBD
cloned  ||| S:26108 E:26115 ||| VBN
into  ||| S:26115 E:26120 ||| IN
the  ||| S:26120 E:26124 ||| DT
vector  ||| S:26124 E:26131 ||| JJ
pEGFP-C3  ||| S:26131 E:26150 ||| NNP
( ||| S:26150 E:26151 ||| -LRB-
Clontech ||| S:26151 E:26159 ||| NNP
)  ||| S:26159 E:26161 ||| -RRB-
to  ||| S:26161 E:26164 ||| TO
create  ||| S:26164 E:26171 ||| VB
pEGFP-cPLA  ||| S:26171 E:26193 ||| JJ
2  ||| S:26193 E:26195 ||| CD
,  ||| S:26195 E:26197 ||| ,
as  ||| S:26197 E:26200 ||| RB
previously  ||| S:26200 E:26211 ||| RB
described  ||| S:26211 E:26221 ||| VBN
[  ||| S:26221 E:26223 ||| -LRB-
15  ||| S:26223 E:26226 ||| CD
]  ||| S:26226 E:26228 ||| -RRB-
.  ||| S:26228 E:26240 ||| .
The  ||| S:26240 E:26244 ||| DT
XbaI ||| S:26244 E:26248 ||| JJ
/ ||| S:26248 E:26249 ||| CD
PstI  ||| S:26249 E:26254 ||| JJ
fragment  ||| S:26254 E:26263 ||| NN
from  ||| S:26263 E:26268 ||| IN
a  ||| S:26268 E:26270 ||| DT
cPLA  ||| S:26270 E:26286 ||| JJ
2  ||| S:26286 E:26288 ||| CD
α  ||| S:26288 E:26290 ||| NNS
clone  ||| S:26290 E:26296 ||| VBP
containing  ||| S:26296 E:26307 ||| VBG
S505A  ||| S:26307 E:26313 ||| NNP
or  ||| S:26313 E:26316 ||| CC
S727A  ||| S:26316 E:26332 ||| CD
mutations  ||| S:26332 E:26342 ||| NNS
[  ||| S:26342 E:26344 ||| -LRB-
13  ||| S:26344 E:26347 ||| CD
]  ||| S:26347 E:26349 ||| -RRB-
was  ||| S:26349 E:26353 ||| VBD
inserted  ||| S:26353 E:26362 ||| VBN
into  ||| S:26362 E:26367 ||| IN
an  ||| S:26367 E:26370 ||| DT
XbaI ||| S:26370 E:26374 ||| JJ
/ ||| S:26374 E:26375 ||| CD
PstI  ||| S:26375 E:26380 ||| JJ
site  ||| S:26380 E:26385 ||| NN
in  ||| S:26385 E:26398 ||| IN
pEGFP-cPLA  ||| S:26398 E:26420 ||| JJ
2  ||| S:26420 E:26422 ||| CD
to  ||| S:26422 E:26425 ||| TO
generate  ||| S:26425 E:26434 ||| VB
pEGFP-cPLA  ||| S:26434 E:26456 ||| JJ
2  ||| S:26456 E:26458 ||| CD
S505A  ||| S:26458 E:26464 ||| CD
and  ||| S:26464 E:26468 ||| CC
pECFP-cPLA  ||| S:26468 E:26490 ||| JJ
2  ||| S:26490 E:26492 ||| CD
S727A ||| S:26492 E:26497 ||| CD
.  ||| S:26497 E:26499 ||| .
Different  ||| S:26499 E:26509 ||| JJ
fluorescent-protein  ||| S:26509 E:26539 ||| JJ
tagged  ||| S:26539 E:26546 ||| JJ
constructs  ||| S:26546 E:26557 ||| NN
were  ||| S:26557 E:26562 ||| VBD
produced  ||| S:26562 E:26571 ||| VBN
by  ||| S:26571 E:26574 ||| IN
exchanging  ||| S:26574 E:26585 ||| VBG
the  ||| S:26585 E:26599 ||| DT
NheI ||| S:26599 E:26603 ||| JJ
/ ||| S:26603 E:26604 ||| CD
BsrGI  ||| S:26604 E:26610 ||| JJ
fragment  ||| S:26610 E:26619 ||| NN
containing  ||| S:26619 E:26630 ||| VBG
the  ||| S:26630 E:26634 ||| DT
fluorescent  ||| S:26634 E:26646 ||| JJ
protein  ||| S:26646 E:26664 ||| NN
coding  ||| S:26664 E:26671 ||| NN
sequence  ||| S:26671 E:26680 ||| NN
between  ||| S:26680 E:26688 ||| IN
EGFP ||| S:26688 E:26692 ||| NNP
,  ||| S:26692 E:26694 ||| ,
EYFP ||| S:26694 E:26698 ||| NNP
,  ||| S:26698 E:26700 ||| ,
and  ||| S:26700 E:26704 ||| CC
ECFP ||| S:26704 E:26708 ||| NNP
.  ||| S:26708 E:26710 ||| .
All  ||| S:26710 E:26724 ||| DT
constructs  ||| S:26724 E:26735 ||| NN
were  ||| S:26735 E:26740 ||| VBD
confirmed  ||| S:26740 E:26750 ||| VBN
by  ||| S:26750 E:26753 ||| IN
sequencing ||| S:26753 E:26763 ||| NN
.  ||| S:26763 E:26793 ||| .
Cell  ||| S:26793 E:26798 ||| NN
culture  ||| S:26798 E:26816 ||| NN
MDCK  ||| S:26816 E:26821 ||| NN
cells  ||| S:26821 E:26827 ||| NNS
obtained  ||| S:26827 E:26836 ||| VBN
from  ||| S:26836 E:26841 ||| IN
ATCC  ||| S:26841 E:26846 ||| NNP
were  ||| S:26846 E:26851 ||| VBD
cultured  ||| S:26851 E:26860 ||| VBN
in  ||| S:26860 E:26863 ||| IN
DMEM  ||| S:26863 E:26878 ||| NNP
containing  ||| S:26878 E:26889 ||| VBG
10 ||| S:26889 E:26891 ||| CD
%  ||| S:26891 E:26893 ||| NN
FBS ||| S:26893 E:26896 ||| NNP
,  ||| S:26896 E:26898 ||| ,
100  ||| S:26898 E:26902 ||| CD
U ||| S:26902 E:26903 ||| NNP
/ ||| S:26903 E:26904 ||| FW
ml  ||| S:26904 E:26907 ||| FW
penicillin ||| S:26907 E:26917 ||| FW
,  ||| S:26917 E:26919 ||| ,
100  ||| S:26919 E:26923 ||| CD
μg ||| S:26923 E:26925 ||| CD
/ ||| S:26925 E:26926 ||| CD
ml  ||| S:26926 E:26939 ||| JJ
streptomycin ||| S:26939 E:26951 ||| NN
,  ||| S:26951 E:26953 ||| ,
0.292  ||| S:26953 E:26959 ||| FW
mg ||| S:26959 E:26961 ||| FW
/ ||| S:26961 E:26962 ||| FW
ml  ||| S:26962 E:26965 ||| FW
glutamine  ||| S:26965 E:26975 ||| FW
( ||| S:26975 E:26976 ||| -LRB-
growth  ||| S:26976 E:26983 ||| NN
medium ||| S:26983 E:26989 ||| NN
)  ||| S:26989 E:26991 ||| -RRB-
in  ||| S:26991 E:26994 ||| IN
5 ||| S:26994 E:26995 ||| CD
%  ||| S:26995 E:27007 ||| NN
CO  ||| S:27007 E:27021 ||| NNP
2  ||| S:27021 E:27023 ||| CD
at  ||| S:27023 E:27026 ||| IN
37°C ||| S:27026 E:27030 ||| CD
.  ||| S:27030 E:27032 ||| .
Subconfluent  ||| S:27032 E:27045 ||| JJ
cells  ||| S:27045 E:27051 ||| NNS
( ||| S:27051 E:27052 ||| -LRB-
5  ||| S:27052 E:27054 ||| CD
×  ||| S:27054 E:27056 ||| CD
10  ||| S:27056 E:27069 ||| CD
3cells ||| S:27069 E:27075 ||| CD
/ ||| S:27075 E:27076 ||| CD
cm  ||| S:27076 E:27079 ||| CD
2 ||| S:27079 E:27080 ||| CD
)  ||| S:27080 E:27082 ||| -RRB-
were  ||| S:27082 E:27087 ||| VBD
transfected  ||| S:27087 E:27099 ||| VBN
with  ||| S:27099 E:27104 ||| IN
2  ||| S:27104 E:27106 ||| CD
μg  ||| S:27106 E:27109 ||| NN
of  ||| S:27109 E:27112 ||| IN
the  ||| S:27112 E:27116 ||| DT
relevant  ||| S:27116 E:27135 ||| JJ
plasmid  ||| S:27135 E:27143 ||| NNS
using  ||| S:27143 E:27149 ||| VBG
Fugene-6  ||| S:27149 E:27158 ||| NNP
( ||| S:27158 E:27159 ||| -LRB-
Boehringer  ||| S:27159 E:27170 ||| NNP
Mannheim ||| S:27170 E:27178 ||| NNP
)  ||| S:27178 E:27180 ||| -RRB-
in  ||| S:27180 E:27183 ||| IN
DMEM  ||| S:27183 E:27198 ||| NNP
containing  ||| S:27198 E:27209 ||| VBG
0.2 ||| S:27209 E:27212 ||| CD
%  ||| S:27212 E:27214 ||| NN
BSA ||| S:27214 E:27217 ||| NNP
,  ||| S:27217 E:27219 ||| ,
100  ||| S:27219 E:27223 ||| CD
U ||| S:27223 E:27224 ||| NNP
/ ||| S:27224 E:27225 ||| FW
ml  ||| S:27225 E:27228 ||| FW
penicillin ||| S:27228 E:27238 ||| FW
,  ||| S:27238 E:27240 ||| ,
100  ||| S:27240 E:27244 ||| CD
μg ||| S:27244 E:27246 ||| CD
/ ||| S:27246 E:27247 ||| CD
ml  ||| S:27247 E:27260 ||| JJ
streptomycin ||| S:27260 E:27272 ||| NN
,  ||| S:27272 E:27274 ||| ,
0.292  ||| S:27274 E:27280 ||| FW
mg ||| S:27280 E:27282 ||| FW
/ ||| S:27282 E:27283 ||| FW
ml  ||| S:27283 E:27286 ||| FW
glutamine  ||| S:27286 E:27296 ||| FW
( ||| S:27296 E:27297 ||| -LRB-
serum-free  ||| S:27297 E:27308 ||| JJ
medium ||| S:27308 E:27314 ||| NN
)  ||| S:27314 E:27326 ||| -RRB-
following  ||| S:27326 E:27336 ||| VBG
the  ||| S:27336 E:27340 ||| DT
manufacturer ||| S:27340 E:27352 ||| NN
's  ||| S:27352 E:27355 ||| POS
protocol ||| S:27355 E:27363 ||| NN
.  ||| S:27363 E:27365 ||| .
Stable  ||| S:27365 E:27372 ||| JJ
lines  ||| S:27372 E:27388 ||| NNS
expressing  ||| S:27388 E:27399 ||| VBG
EGFP-cPLA  ||| S:27399 E:27420 ||| JJ
2  ||| S:27420 E:27422 ||| CD
were  ||| S:27422 E:27427 ||| VBD
generated  ||| S:27427 E:27437 ||| VBN
by  ||| S:27437 E:27440 ||| IN
growing  ||| S:27440 E:27458 ||| VBG
transfected  ||| S:27458 E:27470 ||| JJ
cells  ||| S:27470 E:27476 ||| NNS
in  ||| S:27476 E:27479 ||| IN
growth  ||| S:27479 E:27486 ||| NN
medium  ||| S:27486 E:27493 ||| NN
for  ||| S:27493 E:27497 ||| IN
3  ||| S:27497 E:27499 ||| CD
d ||| S:27499 E:27500 ||| NN
,  ||| S:27500 E:27502 ||| ,
supplementing  ||| S:27502 E:27526 ||| VBG
the  ||| S:27526 E:27530 ||| DT
growth  ||| S:27530 E:27537 ||| NN
medium  ||| S:27537 E:27544 ||| NN
with  ||| S:27544 E:27549 ||| IN
5  ||| S:27549 E:27551 ||| CD
mg ||| S:27551 E:27553 ||| FW
/ ||| S:27553 E:27554 ||| FW
ml  ||| S:27554 E:27557 ||| FW
Geneticin  ||| S:27557 E:27567 ||| FW
( ||| S:27567 E:27568 ||| -LRB-
antibiotic  ||| S:27568 E:27589 ||| FW
G418-sulfate ||| S:27589 E:27601 ||| FW
) ||| S:27601 E:27602 ||| -RRB-
,  ||| S:27602 E:27604 ||| ,
and  ||| S:27604 E:27608 ||| CC
culturing  ||| S:27608 E:27618 ||| NN
for  ||| S:27618 E:27622 ||| IN
an  ||| S:27622 E:27625 ||| DT
additional  ||| S:27625 E:27636 ||| JJ
2  ||| S:27636 E:27638 ||| CD
wk  ||| S:27638 E:27641 ||| NN
in  ||| S:27641 E:27654 ||| IN
Geneticin ||| S:27654 E:27663 ||| NNP
.  ||| S:27663 E:27665 ||| .
Cells  ||| S:27665 E:27671 ||| NNS
expressing  ||| S:27671 E:27682 ||| VBG
EGFP  ||| S:27682 E:27687 ||| NNP
fluorescence  ||| S:27687 E:27700 ||| NN
were  ||| S:27700 E:27715 ||| VBD
selected  ||| S:27715 E:27724 ||| VBN
using  ||| S:27724 E:27730 ||| VBG
a  ||| S:27730 E:27732 ||| DT
fluorescence-activated  ||| S:27732 E:27755 ||| JJ
cell  ||| S:27755 E:27760 ||| NN
sorter ||| S:27760 E:27766 ||| NN
.  ||| S:27766 E:27768 ||| .
The  ||| S:27768 E:27782 ||| DT
EGFP-positive  ||| S:27782 E:27796 ||| JJ
cells  ||| S:27796 E:27802 ||| NNS
were  ||| S:27802 E:27807 ||| VBD
maintained  ||| S:27807 E:27818 ||| VBN
in  ||| S:27818 E:27821 ||| IN
growth  ||| S:27821 E:27828 ||| NN
medium  ||| S:27828 E:27845 ||| NN
supplemented  ||| S:27845 E:27858 ||| NN
with  ||| S:27858 E:27863 ||| IN
5  ||| S:27863 E:27865 ||| CD
mg ||| S:27865 E:27867 ||| FW
/ ||| S:27867 E:27868 ||| FW
ml  ||| S:27868 E:27871 ||| FW
Geneticin ||| S:27871 E:27880 ||| FW
.  ||| S:27880 E:27882 ||| .
For  ||| S:27882 E:27886 ||| IN
imaging  ||| S:27886 E:27894 ||| JJ
studies ||| S:27894 E:27901 ||| NNS
,  ||| S:27901 E:27913 ||| ,
MDCK  ||| S:27913 E:27918 ||| NNP
cells  ||| S:27918 E:27924 ||| NNS
were  ||| S:27924 E:27929 ||| VBD
plated  ||| S:27929 E:27936 ||| VBN
on  ||| S:27936 E:27939 ||| IN
glass-bottomed  ||| S:27939 E:27954 ||| JJ
35  ||| S:27954 E:27957 ||| CD
mm  ||| S:27957 E:27960 ||| JJ
culture  ||| S:27960 E:27978 ||| NN
dishes  ||| S:27978 E:27985 ||| NNS
( ||| S:27985 E:27986 ||| -LRB-
MatTek ||| S:27986 E:27992 ||| NNP
)  ||| S:27992 E:27994 ||| -RRB-
at  ||| S:27994 E:27997 ||| IN
5  ||| S:27997 E:27999 ||| CD
×  ||| S:27999 E:28001 ||| CD
10  ||| S:28001 E:28004 ||| CD
3cells ||| S:28004 E:28010 ||| CD
/ ||| S:28010 E:28011 ||| CD
cm  ||| S:28011 E:28014 ||| CD
2in  ||| S:28014 E:28018 ||| CD
growth  ||| S:28018 E:28025 ||| NN
medium  ||| S:28025 E:28032 ||| NN
and  ||| S:28032 E:28046 ||| CC
incubated  ||| S:28046 E:28056 ||| JJ
overnight ||| S:28056 E:28065 ||| JJ
,  ||| S:28065 E:28067 ||| ,
transfected  ||| S:28067 E:28079 ||| VBG
with  ||| S:28079 E:28084 ||| IN
the  ||| S:28084 E:28088 ||| DT
relevant  ||| S:28088 E:28107 ||| JJ
plasmid ||| S:28107 E:28114 ||| NNS
( ||| S:28114 E:28115 ||| -LRB-
s ||| S:28115 E:28116 ||| LS
) ||| S:28116 E:28117 ||| -RRB-
,  ||| S:28117 E:28119 ||| ,
changed  ||| S:28119 E:28127 ||| VBN
into  ||| S:28127 E:28132 ||| IN
serum-free  ||| S:28132 E:28143 ||| JJ
medium  ||| S:28143 E:28150 ||| NN
to  ||| S:28150 E:28153 ||| TO
quiesce  ||| S:28153 E:28161 ||| VB
the  ||| S:28161 E:28175 ||| DT
cells ||| S:28175 E:28180 ||| NNS
,  ||| S:28180 E:28182 ||| ,
incubated  ||| S:28182 E:28192 ||| JJ
overnight ||| S:28192 E:28201 ||| JJ
,  ||| S:28201 E:28203 ||| ,
and  ||| S:28203 E:28207 ||| CC
used  ||| S:28207 E:28212 ||| VBD
the  ||| S:28212 E:28216 ||| DT
next  ||| S:28216 E:28221 ||| JJ
day ||| S:28221 E:28224 ||| NN
.  ||| S:28224 E:28254 ||| .
Immunoblotting  ||| S:28254 E:28279 ||| NNP
Stable  ||| S:28279 E:28286 ||| NNP
EGFP-cPLA  ||| S:28286 E:28307 ||| NNP
2  ||| S:28307 E:28309 ||| CD
transfectants  ||| S:28309 E:28323 ||| NNS
were  ||| S:28323 E:28328 ||| VBD
grown  ||| S:28328 E:28334 ||| VBN
on  ||| S:28334 E:28337 ||| IN
100  ||| S:28337 E:28341 ||| CD
mm  ||| S:28341 E:28354 ||| CD
dishes  ||| S:28354 E:28361 ||| NNS
at  ||| S:28361 E:28364 ||| IN
5  ||| S:28364 E:28366 ||| CD
×  ||| S:28366 E:28368 ||| CD
10  ||| S:28368 E:28371 ||| CD
3cells ||| S:28371 E:28377 ||| CD
/ ||| S:28377 E:28378 ||| CD
cm  ||| S:28378 E:28381 ||| CD
2in  ||| S:28381 E:28385 ||| CD
growth  ||| S:28385 E:28392 ||| NN
medium  ||| S:28392 E:28399 ||| NN
for  ||| S:28399 E:28403 ||| IN
one  ||| S:28403 E:28407 ||| CD
day ||| S:28407 E:28410 ||| NN
,  ||| S:28410 E:28422 ||| ,
then  ||| S:28422 E:28427 ||| RB
quiesced  ||| S:28427 E:28436 ||| VBN
in  ||| S:28436 E:28439 ||| IN
serum-free  ||| S:28439 E:28450 ||| JJ
medium  ||| S:28450 E:28457 ||| NN
overnight ||| S:28457 E:28466 ||| RB
.  ||| S:28466 E:28468 ||| .
Cells  ||| S:28468 E:28474 ||| NNS
were  ||| S:28474 E:28489 ||| VBD
scraped  ||| S:28489 E:28497 ||| VBN
into  ||| S:28497 E:28502 ||| IN
ice-cold  ||| S:28502 E:28511 ||| JJ
lysis  ||| S:28511 E:28517 ||| JJ
buffer ||| S:28517 E:28523 ||| NN
:  ||| S:28523 E:28525 ||| :
50  ||| S:28525 E:28528 ||| CD
mM  ||| S:28528 E:28531 ||| JJ
HEPES ||| S:28531 E:28536 ||| NNP
,  ||| S:28536 E:28538 ||| ,
pH  ||| S:28538 E:28541 ||| JJ
7.4 ||| S:28541 E:28544 ||| CD
,  ||| S:28544 E:28556 ||| ,
150  ||| S:28556 E:28560 ||| CD
mM  ||| S:28560 E:28563 ||| JJ
sodium  ||| S:28563 E:28570 ||| JJ
chloride ||| S:28570 E:28578 ||| NN
,  ||| S:28578 E:28580 ||| ,
1.5  ||| S:28580 E:28584 ||| CD
mM  ||| S:28584 E:28587 ||| JJ
magnesium  ||| S:28587 E:28597 ||| JJ
chloride ||| S:28597 E:28605 ||| NN
,  ||| S:28605 E:28607 ||| ,
10 ||| S:28607 E:28609 ||| CD
%  ||| S:28609 E:28621 ||| NN
glycerol ||| S:28621 E:28629 ||| NN
,  ||| S:28629 E:28631 ||| ,
1 ||| S:28631 E:28632 ||| CD
%  ||| S:28632 E:28634 ||| NN
Triton  ||| S:28634 E:28641 ||| NNP
X-100 ||| S:28641 E:28646 ||| NNP
,  ||| S:28646 E:28648 ||| ,
1  ||| S:28648 E:28650 ||| CD
mM  ||| S:28650 E:28653 ||| JJ
EGTA ||| S:28653 E:28657 ||| NNP
,  ||| S:28657 E:28659 ||| ,
200  ||| S:28659 E:28663 ||| CD
μM  ||| S:28663 E:28666 ||| JJ
sodium  ||| S:28666 E:28683 ||| JJ
vanadate ||| S:28683 E:28691 ||| NN
,  ||| S:28691 E:28693 ||| ,
10  ||| S:28693 E:28696 ||| CD
mM  ||| S:28696 E:28699 ||| JJ
tetrasodium  ||| S:28699 E:28711 ||| JJ
pyrophosphate ||| S:28711 E:28724 ||| NN
,  ||| S:28724 E:28726 ||| ,
100  ||| S:28726 E:28730 ||| CD
mM  ||| S:28730 E:28733 ||| JJ
sodium  ||| S:28733 E:28750 ||| JJ
fluoride ||| S:28750 E:28758 ||| NN
,  ||| S:28758 E:28760 ||| ,
10  ||| S:28760 E:28763 ||| CD
μg ||| S:28763 E:28765 ||| CD
/ ||| S:28765 E:28766 ||| CD
ml  ||| S:28766 E:28769 ||| JJ
leupeptin ||| S:28769 E:28778 ||| NN
,  ||| S:28778 E:28780 ||| ,
and  ||| S:28780 E:28784 ||| CC
10  ||| S:28784 E:28787 ||| CD
μg ||| S:28787 E:28789 ||| CD
/ ||| S:28789 E:28790 ||| CD
ml  ||| S:28790 E:28793 ||| CD
aprotinin ||| S:28793 E:28802 ||| NNS
.  ||| S:28802 E:28814 ||| .
Lysates  ||| S:28814 E:28822 ||| NNP
were  ||| S:28822 E:28827 ||| VBD
centrifuged  ||| S:28827 E:28839 ||| VBN
at  ||| S:28839 E:28842 ||| IN
15,000  ||| S:28842 E:28849 ||| CD
×  ||| S:28849 E:28862 ||| CD
g  ||| S:28862 E:28864 ||| NN
for  ||| S:28864 E:28868 ||| IN
15  ||| S:28868 E:28871 ||| CD
min ||| S:28871 E:28874 ||| NN
,  ||| S:28874 E:28876 ||| ,
and  ||| S:28876 E:28880 ||| CC
protein  ||| S:28880 E:28898 ||| NN
concentration  ||| S:28898 E:28912 ||| NN
of  ||| S:28912 E:28915 ||| IN
the  ||| S:28915 E:28919 ||| DT
supernatant  ||| S:28919 E:28931 ||| NN
was  ||| S:28931 E:28935 ||| VBD
determined  ||| S:28935 E:28946 ||| VBN
by  ||| S:28946 E:28949 ||| IN
the  ||| S:28949 E:28963 ||| DT
bicinchoninic  ||| S:28963 E:28977 ||| JJ
acid  ||| S:28977 E:28982 ||| NN
method ||| S:28982 E:28988 ||| NN
.  ||| S:28988 E:28990 ||| .
Laemmli  ||| S:28990 E:28998 ||| FW
electrophoresis  ||| S:28998 E:29014 ||| FW
sample  ||| S:29014 E:29031 ||| FW
buffer  ||| S:29031 E:29038 ||| FW
( ||| S:29038 E:29039 ||| -LRB-
5× ||| S:29039 E:29041 ||| NNP
)  ||| S:29041 E:29043 ||| -RRB-
was  ||| S:29043 E:29047 ||| VBD
added  ||| S:29047 E:29053 ||| VBN
to  ||| S:29053 E:29056 ||| TO
the  ||| S:29056 E:29060 ||| DT
lysates ||| S:29060 E:29067 ||| NN
,  ||| S:29067 E:29069 ||| ,
and  ||| S:29069 E:29083 ||| CC
SDS-polyacrylamide  ||| S:29083 E:29102 ||| JJ
gel  ||| S:29102 E:29106 ||| JJ
electrophoresis  ||| S:29106 E:29122 ||| NN
and  ||| S:29122 E:29126 ||| CC
immunoblotting  ||| S:29126 E:29151 ||| NNS
were  ||| S:29151 E:29156 ||| VBD
performed  ||| S:29156 E:29166 ||| VBN
using  ||| S:29166 E:29172 ||| VBG
35  ||| S:29172 E:29175 ||| CD
μg  ||| S:29175 E:29178 ||| CD
lysate  ||| S:29178 E:29185 ||| JJ
protein ||| S:29185 E:29192 ||| NN
,  ||| S:29192 E:29204 ||| ,
phospho-specific  ||| S:29204 E:29221 ||| JJ
antibodies  ||| S:29221 E:29232 ||| NNS
for  ||| S:29232 E:29236 ||| IN
ERK  ||| S:29236 E:29240 ||| NNP
and  ||| S:29240 E:29244 ||| CC
p38 ||| S:29244 E:29247 ||| NNP
,  ||| S:29247 E:29249 ||| ,
and  ||| S:29249 E:29253 ||| CC
rabbit  ||| S:29253 E:29270 ||| JJ
polyclonal  ||| S:29270 E:29281 ||| JJ
antibody  ||| S:29281 E:29290 ||| NN
for  ||| S:29290 E:29294 ||| IN
cPLA  ||| S:29294 E:29310 ||| JJ
2  ||| S:29310 E:29312 ||| CD
[  ||| S:29312 E:29314 ||| -LRB-
21  ||| S:29314 E:29317 ||| CD
]  ||| S:29317 E:29319 ||| -RRB-
.  ||| S:29319 E:29349 ||| .
Dual  ||| S:29349 E:29354 ||| JJ
imaging  ||| S:29354 E:29362 ||| NN
microscopy  ||| S:29362 E:29373 ||| NN
of  ||| S:29373 E:29376 ||| IN
fluorescent  ||| S:29376 E:29388 ||| JJ
protein  ||| S:29388 E:29406 ||| NN
translocation  ||| S:29406 E:29430 ||| NN
In  ||| S:29430 E:29433 ||| IN
order  ||| S:29433 E:29439 ||| NN
to  ||| S:29439 E:29442 ||| TO
compare  ||| S:29442 E:29450 ||| VB
the  ||| S:29450 E:29454 ||| DT
characteristics  ||| S:29454 E:29470 ||| NN
of  ||| S:29470 E:29473 ||| IN
full-length  ||| S:29473 E:29495 ||| JJ
cPLA  ||| S:29495 E:29511 ||| JJ
2  ||| S:29511 E:29513 ||| CD
and  ||| S:29513 E:29517 ||| CC
cPLA  ||| S:29517 E:29533 ||| JJ
2  ||| S:29533 E:29535 ||| CD
S505A  ||| S:29535 E:29541 ||| CD
or  ||| S:29541 E:29544 ||| CC
cPLA  ||| S:29544 E:29560 ||| JJ
2  ||| S:29560 E:29562 ||| CD
S727A  ||| S:29562 E:29568 ||| CD
translocation ||| S:29568 E:29581 ||| NN
,  ||| S:29581 E:29583 ||| ,
while  ||| S:29583 E:29599 ||| IN
controlling  ||| S:29599 E:29611 ||| VBG
for  ||| S:29611 E:29615 ||| IN
cell-to-cell  ||| S:29615 E:29628 ||| JJ
heterogeneity ||| S:29628 E:29641 ||| NN
,  ||| S:29641 E:29643 ||| ,
we  ||| S:29643 E:29646 ||| PRP
used  ||| S:29646 E:29651 ||| VBD
a  ||| S:29651 E:29663 ||| DT
dual  ||| S:29663 E:29668 ||| JJ
CFP ||| S:29668 E:29671 ||| NNP
/ ||| S:29671 E:29672 ||| NNP
YFP  ||| S:29672 E:29676 ||| NNP
imaging  ||| S:29676 E:29684 ||| NN
approach ||| S:29684 E:29692 ||| NN
.  ||| S:29692 E:29694 ||| .
EYFP-cPLA  ||| S:29694 E:29715 ||| JJ
2  ||| S:29715 E:29717 ||| CD
/ ||| S:29717 E:29718 ||| CD
ECFP-cPLA  ||| S:29718 E:29739 ||| JJ
2  ||| S:29739 E:29741 ||| CD
S505A-  ||| S:29741 E:29748 ||| CD
or  ||| S:29748 E:29751 ||| CC
pECFP-cPLA  ||| S:29751 E:29773 ||| JJ
2  ||| S:29773 E:29775 ||| CD
S727A-transfected  ||| S:29775 E:29793 ||| CD
MDCK  ||| S:29793 E:29798 ||| NN
cells  ||| S:29798 E:29804 ||| NNS
grown  ||| S:29804 E:29820 ||| VBN
on  ||| S:29820 E:29823 ||| IN
MatTek  ||| S:29823 E:29830 ||| JJ
plates  ||| S:29830 E:29837 ||| NN
were  ||| S:29837 E:29842 ||| VBD
quiesced  ||| S:29842 E:29851 ||| JJ
overnight  ||| S:29851 E:29861 ||| JJ
in  ||| S:29861 E:29864 ||| IN
serum-free  ||| S:29864 E:29885 ||| JJ
medium ||| S:29885 E:29891 ||| NN
,  ||| S:29891 E:29893 ||| ,
washed  ||| S:29893 E:29900 ||| VBN
with  ||| S:29900 E:29905 ||| IN
and  ||| S:29905 E:29909 ||| CC
incubated  ||| S:29909 E:29919 ||| NN
in  ||| S:29919 E:29922 ||| IN
Hank ||| S:29922 E:29926 ||| NNP
's  ||| S:29926 E:29929 ||| POS
balanced  ||| S:29929 E:29938 ||| JJ
salt  ||| S:29938 E:29953 ||| NN
solution  ||| S:29953 E:29962 ||| NN
( ||| S:29962 E:29963 ||| -LRB-
HBSS ||| S:29963 E:29967 ||| NNP
)  ||| S:29967 E:29969 ||| -RRB-
additionally  ||| S:29969 E:29982 ||| RB
buffered  ||| S:29982 E:29991 ||| VBN
with  ||| S:29991 E:29996 ||| IN
25  ||| S:29996 E:29999 ||| CD
mM  ||| S:29999 E:30002 ||| JJ
HEPES  ||| S:30002 E:30008 ||| NNP
pH  ||| S:30008 E:30021 ||| NNP
7.4  ||| S:30021 E:30025 ||| CD
( ||| S:30025 E:30026 ||| -LRB-
HHBSS ||| S:30026 E:30031 ||| NNP
) ||| S:30031 E:30032 ||| -RRB-
.  ||| S:30032 E:30034 ||| .
Cells  ||| S:30034 E:30040 ||| NNS
were  ||| S:30040 E:30045 ||| VBD
imaged  ||| S:30045 E:30052 ||| VBN
using  ||| S:30052 E:30058 ||| VBG
an  ||| S:30058 E:30061 ||| DT
Olympus  ||| S:30061 E:30069 ||| JJ
inverted  ||| S:30069 E:30088 ||| NNS
microscope  ||| S:30088 E:30099 ||| VBP
equipped  ||| S:30099 E:30108 ||| VBN
with  ||| S:30108 E:30113 ||| IN
a  ||| S:30113 E:30115 ||| DT
60× ||| S:30115 E:30118 ||| NNP
,  ||| S:30118 E:30120 ||| ,
1.25  ||| S:30120 E:30125 ||| CD
NA  ||| S:30125 E:30128 ||| JJ
oil  ||| S:30128 E:30132 ||| NN
immersion  ||| S:30132 E:30152 ||| NN
objective ||| S:30152 E:30161 ||| NN
,  ||| S:30161 E:30163 ||| ,
CFP  ||| S:30163 E:30167 ||| NNP
and  ||| S:30167 E:30171 ||| CC
YFP  ||| S:30171 E:30175 ||| NNP
emission  ||| S:30175 E:30184 ||| NN
filters  ||| S:30184 E:30192 ||| NNS
( ||| S:30192 E:30193 ||| -LRB-
Chroma ||| S:30193 E:30199 ||| NNP
)  ||| S:30199 E:30201 ||| -RRB-
in  ||| S:30201 E:30204 ||| IN
a  ||| S:30204 E:30216 ||| DT
Sutter  ||| S:30216 E:30223 ||| JJ
filter  ||| S:30223 E:30230 ||| JJ
wheel ||| S:30230 E:30235 ||| NN
,  ||| S:30235 E:30237 ||| ,
a  ||| S:30237 E:30239 ||| DT
dual  ||| S:30239 E:30244 ||| JJ
CFP ||| S:30244 E:30247 ||| NNP
/ ||| S:30247 E:30248 ||| NNP
YFP  ||| S:30248 E:30252 ||| NNP
dichroic  ||| S:30252 E:30261 ||| JJ
mirror ||| S:30261 E:30267 ||| NN
,  ||| S:30267 E:30269 ||| ,
and  ||| S:30269 E:30283 ||| CC
a  ||| S:30283 E:30285 ||| DT
TILL  ||| S:30285 E:30290 ||| NNP
Imago  ||| S:30290 E:30296 ||| NNP
CCD  ||| S:30296 E:30300 ||| NNP
camera  ||| S:30300 E:30307 ||| NN
( ||| S:30307 E:30308 ||| -LRB-
TILL  ||| S:30308 E:30313 ||| NNP
Photonics ||| S:30313 E:30322 ||| NNP
) ||| S:30322 E:30323 ||| -RRB-
.  ||| S:30323 E:30325 ||| .
Excitation  ||| S:30325 E:30346 ||| JJ
light  ||| S:30346 E:30352 ||| NN
of  ||| S:30352 E:30355 ||| IN
430  ||| S:30355 E:30359 ||| CD
and  ||| S:30359 E:30363 ||| CC
510  ||| S:30363 E:30367 ||| CD
nm  ||| S:30367 E:30370 ||| NN
for  ||| S:30370 E:30374 ||| IN
CFP  ||| S:30374 E:30378 ||| NNP
and  ||| S:30378 E:30382 ||| CC
YFP ||| S:30382 E:30385 ||| NNP
,  ||| S:30385 E:30387 ||| ,
respectively ||| S:30387 E:30399 ||| RB
,  ||| S:30399 E:30411 ||| ,
was  ||| S:30411 E:30415 ||| VBD
provided  ||| S:30415 E:30424 ||| VBN
using  ||| S:30424 E:30430 ||| VBG
a  ||| S:30430 E:30432 ||| DT
Polychrome  ||| S:30432 E:30443 ||| NNP
IV  ||| S:30443 E:30446 ||| NNP
monochromator  ||| S:30446 E:30460 ||| NNS
( ||| S:30460 E:30461 ||| -LRB-
TILL  ||| S:30461 E:30476 ||| NNP
Photonics ||| S:30476 E:30485 ||| NNP
) ||| S:30485 E:30486 ||| -RRB-
.  ||| S:30486 E:30488 ||| .
TILLvisION  ||| S:30488 E:30499 ||| JJ
software  ||| S:30499 E:30508 ||| NN
was  ||| S:30508 E:30512 ||| VBD
used  ||| S:30512 E:30517 ||| VBN
for  ||| S:30517 E:30521 ||| IN
acquisition  ||| S:30521 E:30543 ||| NN
and  ||| S:30543 E:30547 ||| CC
analysis ||| S:30547 E:30555 ||| NN
.  ||| S:30555 E:30557 ||| .
Bleach  ||| S:30557 E:30564 ||| JJ
values  ||| S:30564 E:30571 ||| NNS
for  ||| S:30571 E:30575 ||| IN
ECFP  ||| S:30575 E:30580 ||| NNP
and  ||| S:30580 E:30584 ||| CC
EYFP  ||| S:30584 E:30589 ||| NNP
were  ||| S:30589 E:30604 ||| VBD
calculated  ||| S:30604 E:30615 ||| VBN
by  ||| S:30615 E:30618 ||| IN
determining  ||| S:30618 E:30630 ||| VBG
the  ||| S:30630 E:30634 ||| DT
background-corrected  ||| S:30634 E:30665 ||| JJ
fluorescence  ||| S:30665 E:30678 ||| NN
for  ||| S:30678 E:30682 ||| IN
the  ||| S:30682 E:30686 ||| DT
entire  ||| S:30686 E:30693 ||| JJ
cell  ||| S:30693 E:30698 ||| NN
with  ||| S:30698 E:30703 ||| IN
respect  ||| S:30703 E:30711 ||| NN
to  ||| S:30711 E:30714 ||| TO
time  ||| S:30714 E:30719 ||| NN
and  ||| S:30719 E:30733 ||| CC
normalizing  ||| S:30733 E:30745 ||| VBG
each  ||| S:30745 E:30750 ||| DT
value  ||| S:30750 E:30756 ||| NN
to  ||| S:30756 E:30759 ||| TO
the  ||| S:30759 E:30763 ||| DT
initial  ||| S:30763 E:30771 ||| JJ
value ||| S:30771 E:30776 ||| NN
.  ||| S:30776 E:30778 ||| .
ECFP ||| S:30778 E:30782 ||| NNP
/ ||| S:30782 E:30783 ||| NNP
EYFP  ||| S:30783 E:30798 ||| NNP
fluorescence  ||| S:30798 E:30811 ||| NN
changes  ||| S:30811 E:30819 ||| NNS
with  ||| S:30819 E:30824 ||| IN
respect  ||| S:30824 E:30832 ||| NN
to  ||| S:30832 E:30835 ||| TO
time  ||| S:30835 E:30840 ||| NN
for  ||| S:30840 E:30844 ||| IN
regions  ||| S:30844 E:30852 ||| NNS
of  ||| S:30852 E:30865 ||| IN
interest  ||| S:30865 E:30874 ||| NN
corresponding  ||| S:30874 E:30888 ||| NN
to  ||| S:30888 E:30891 ||| TO
an  ||| S:30891 E:30894 ||| DT
area  ||| S:30894 E:30899 ||| NN
of  ||| S:30899 E:30902 ||| IN
Golgi  ||| S:30902 E:30908 ||| NNP
membrane  ||| S:30908 E:30917 ||| NN
were  ||| S:30917 E:30932 ||| VBD
determined  ||| S:30932 E:30943 ||| VBN
by  ||| S:30943 E:30946 ||| IN
calculating  ||| S:30946 E:30958 ||| VBG
the  ||| S:30958 E:30962 ||| DT
F  ||| S:30962 E:30975 ||| NN
t  ||| S:30975 E:30977 ||| VBD
/ ||| S:30977 E:30978 ||| CD
F  ||| S:30978 E:30991 ||| NN
0  ||| S:30991 E:30993 ||| CD
,  ||| S:30993 E:30995 ||| ,
where  ||| S:30995 E:31001 ||| WRB
F  ||| S:31001 E:31014 ||| NN
t  ||| S:31014 E:31016 ||| NN
is  ||| S:31016 E:31019 ||| VBZ
the  ||| S:31019 E:31023 ||| DT
background-  ||| S:31023 E:31035 ||| JJ
and  ||| S:31035 E:31049 ||| CC
bleach-corrected  ||| S:31049 E:31066 ||| NNP
ECFP  ||| S:31066 E:31071 ||| NNP
or  ||| S:31071 E:31074 ||| CC
EYFP  ||| S:31074 E:31079 ||| NNP
fluorescence  ||| S:31079 E:31092 ||| NN
at  ||| S:31092 E:31095 ||| IN
time  ||| S:31095 E:31100 ||| NN
=  ||| S:31100 E:31102 ||| SYM
t  ||| S:31102 E:31114 ||| FW
and  ||| S:31114 E:31118 ||| CC
F  ||| S:31118 E:31131 ||| NNP
0  ||| S:31131 E:31133 ||| CD
is  ||| S:31133 E:31136 ||| VBZ
the  ||| S:31136 E:31140 ||| DT
background-corrected  ||| S:31140 E:31161 ||| JJ
ECFP  ||| S:31161 E:31166 ||| NNP
or  ||| S:31166 E:31179 ||| CC
EYFP  ||| S:31179 E:31184 ||| NNP
fluorescence  ||| S:31184 E:31197 ||| NN
at  ||| S:31197 E:31200 ||| IN
time  ||| S:31200 E:31205 ||| NN
=  ||| S:31205 E:31207 ||| SYM
0  ||| S:31207 E:31209 ||| CD
s ||| S:31209 E:31210 ||| NNS
.  ||| S:31210 E:31212 ||| .
Fluorescence  ||| S:31212 E:31225 ||| NNP
was  ||| S:31225 E:31239 ||| VBD
normalized  ||| S:31239 E:31250 ||| VBN
to  ||| S:31250 E:31253 ||| TO
the  ||| S:31253 E:31257 ||| DT
F  ||| S:31257 E:31270 ||| NN
0  ||| S:31270 E:31272 ||| CD
value ||| S:31272 E:31277 ||| NN
,  ||| S:31277 E:31279 ||| ,
which  ||| S:31279 E:31285 ||| WDT
resulted  ||| S:31285 E:31294 ||| VBD
in  ||| S:31294 E:31297 ||| IN
F  ||| S:31297 E:31310 ||| NN
t  ||| S:31310 E:31312 ||| VBD
/ ||| S:31312 E:31313 ||| CD
F  ||| S:31313 E:31326 ||| NN
0  ||| S:31326 E:31328 ||| CD
representing  ||| S:31328 E:31341 ||| VBG
the  ||| S:31341 E:31345 ||| DT
fraction  ||| S:31345 E:31354 ||| NN
of  ||| S:31354 E:31357 ||| IN
total  ||| S:31357 E:31373 ||| JJ
cell  ||| S:31373 E:31378 ||| NN
fluorescence  ||| S:31378 E:31391 ||| NN
at  ||| S:31391 E:31394 ||| IN
Golgi ||| S:31394 E:31399 ||| NNP
.  ||| S:31399 E:31401 ||| .
Final  ||| S:31401 E:31407 ||| JJ
images  ||| S:31407 E:31414 ||| NNS
were  ||| S:31414 E:31419 ||| VBD
produced  ||| S:31419 E:31438 ||| VBN
using  ||| S:31438 E:31444 ||| VBG
Adobe  ||| S:31444 E:31450 ||| NNP
Photoshop ||| S:31450 E:31459 ||| NNP
.  ||| S:31459 E:31489 ||| .
Calcium  ||| S:31489 E:31497 ||| JJ
imaging  ||| S:31497 E:31515 ||| NN
MDCK  ||| S:31515 E:31520 ||| NN
cells  ||| S:31520 E:31526 ||| NNS
grown  ||| S:31526 E:31532 ||| VBN
on  ||| S:31532 E:31535 ||| IN
MatTek  ||| S:31535 E:31542 ||| JJ
plates  ||| S:31542 E:31549 ||| NN
were  ||| S:31549 E:31554 ||| VBD
quiesced  ||| S:31554 E:31573 ||| JJ
overnight  ||| S:31573 E:31583 ||| JJ
in  ||| S:31583 E:31586 ||| IN
serum-free  ||| S:31586 E:31597 ||| JJ
medium ||| S:31597 E:31603 ||| NN
,  ||| S:31603 E:31605 ||| ,
washed  ||| S:31605 E:31612 ||| VBN
with  ||| S:31612 E:31617 ||| IN
HHBSS  ||| S:31617 E:31633 ||| NNP
containing  ||| S:31633 E:31644 ||| VBG
1  ||| S:31644 E:31646 ||| CD
mM  ||| S:31646 E:31649 ||| JJ
probenecid  ||| S:31649 E:31660 ||| NN
and  ||| S:31660 E:31664 ||| CC
incubated  ||| S:31664 E:31674 ||| NN
with  ||| S:31674 E:31679 ||| IN
5  ||| S:31679 E:31681 ||| CD
μM  ||| S:31681 E:31694 ||| JJ
Fura2-AM  ||| S:31694 E:31703 ||| NNP
( ||| S:31703 E:31704 ||| -LRB-
Calbiochem ||| S:31704 E:31714 ||| NNP
)  ||| S:31714 E:31716 ||| -RRB-
in  ||| S:31716 E:31719 ||| IN
HHBSS ||| S:31719 E:31724 ||| NNP
,  ||| S:31724 E:31726 ||| ,
1  ||| S:31726 E:31728 ||| CD
mM  ||| S:31728 E:31731 ||| JJ
probenecid ||| S:31731 E:31741 ||| NN
,  ||| S:31741 E:31743 ||| ,
and  ||| S:31743 E:31747 ||| CC
1 ||| S:31747 E:31748 ||| CD
%  ||| S:31748 E:31760 ||| NN
DMSO  ||| S:31760 E:31765 ||| NN
for  ||| S:31765 E:31769 ||| IN
45  ||| S:31769 E:31772 ||| CD
min  ||| S:31772 E:31776 ||| NN
at  ||| S:31776 E:31779 ||| IN
37°C ||| S:31779 E:31783 ||| CD
.  ||| S:31783 E:31785 ||| .
Cells  ||| S:31785 E:31791 ||| NNS
were  ||| S:31791 E:31796 ||| VBD
then  ||| S:31796 E:31801 ||| RB
washed  ||| S:31801 E:31808 ||| VBN
with  ||| S:31808 E:31823 ||| IN
HHBSS  ||| S:31823 E:31829 ||| NNP
containing  ||| S:31829 E:31840 ||| VBG
1  ||| S:31840 E:31842 ||| CD
mM  ||| S:31842 E:31845 ||| JJ
probenecid  ||| S:31845 E:31856 ||| NN
and  ||| S:31856 E:31860 ||| CC
imaged  ||| S:31860 E:31867 ||| NN
after  ||| S:31867 E:31873 ||| IN
a  ||| S:31873 E:31875 ||| DT
30  ||| S:31875 E:31888 ||| CD
min  ||| S:31888 E:31892 ||| JJ
incubation  ||| S:31892 E:31903 ||| NN
for  ||| S:31903 E:31907 ||| IN
de-esterification  ||| S:31907 E:31925 ||| JJ
of  ||| S:31925 E:31928 ||| IN
the  ||| S:31928 E:31932 ||| DT
Fura2-AM ||| S:31932 E:31940 ||| NN
.  ||| S:31940 E:31952 ||| .
Single-cell  ||| S:31952 E:31964 ||| JJ
imaging  ||| S:31964 E:31972 ||| NN
was  ||| S:31972 E:31976 ||| VBD
performed  ||| S:31976 E:31986 ||| VBN
on  ||| S:31986 E:31989 ||| IN
the  ||| S:31989 E:31993 ||| DT
Olympus  ||| S:31993 E:32001 ||| JJ
system  ||| S:32001 E:32018 ||| NN
described  ||| S:32018 E:32028 ||| VBD
above ||| S:32028 E:32033 ||| RB
,  ||| S:32033 E:32035 ||| ,
but  ||| S:32035 E:32039 ||| CC
using  ||| S:32039 E:32045 ||| VBG
a  ||| S:32045 E:32047 ||| DT
40× ||| S:32047 E:32050 ||| NNP
,  ||| S:32050 E:32052 ||| ,
1.35  ||| S:32052 E:32057 ||| CD
NA  ||| S:32057 E:32060 ||| JJ
oil  ||| S:32060 E:32064 ||| NN
immersion  ||| S:32064 E:32084 ||| NN
objective  ||| S:32084 E:32094 ||| NN
and  ||| S:32094 E:32098 ||| CC
a  ||| S:32098 E:32100 ||| DT
Fura2  ||| S:32100 E:32106 ||| JJ
dichroic  ||| S:32106 E:32115 ||| JJ
mirror  ||| S:32115 E:32122 ||| NN
and  ||| S:32122 E:32126 ||| CC
emission  ||| S:32126 E:32135 ||| JJ
filter  ||| S:32135 E:32152 ||| NNS
( ||| S:32152 E:32153 ||| -LRB-
Chroma ||| S:32153 E:32159 ||| NNP
) ||| S:32159 E:32160 ||| -RRB-
.  ||| S:32160 E:32162 ||| .
Fura2  ||| S:32162 E:32168 ||| NNP
image  ||| S:32168 E:32174 ||| NN
pairs  ||| S:32174 E:32180 ||| NN
illuminated  ||| S:32180 E:32192 ||| NN
at  ||| S:32192 E:32195 ||| IN
340  ||| S:32195 E:32199 ||| CD
and  ||| S:32199 E:32203 ||| CC
380  ||| S:32203 E:32207 ||| CD
nm  ||| S:32207 E:32220 ||| NNS
were  ||| S:32220 E:32225 ||| VBD
taken  ||| S:32225 E:32231 ||| VBN
at  ||| S:32231 E:32234 ||| IN
1  ||| S:32234 E:32236 ||| CD
Hz ||| S:32236 E:32238 ||| NNP
.  ||| S:32238 E:32240 ||| .
The  ||| S:32240 E:32244 ||| DT
[ ||| S:32244 E:32245 ||| -LRB-
Ca  ||| S:32245 E:32248 ||| NNP
2+ ||| S:32248 E:32250 ||| NNP
]  ||| S:32250 E:32263 ||| -RRB-
i  ||| S:32263 E:32265 ||| FW
increase  ||| S:32265 E:32274 ||| NN
is  ||| S:32274 E:32277 ||| VBZ
expressed  ||| S:32277 E:32287 ||| VBN
as  ||| S:32287 E:32290 ||| IN
the  ||| S:32290 E:32294 ||| DT
ratio  ||| S:32294 E:32310 ||| NN
of  ||| S:32310 E:32313 ||| IN
the  ||| S:32313 E:32317 ||| DT
background-corrected  ||| S:32317 E:32338 ||| JJ
Fura2  ||| S:32338 E:32344 ||| CD
fluorescence  ||| S:32344 E:32357 ||| NN
at  ||| S:32357 E:32360 ||| IN
340  ||| S:32360 E:32364 ||| CD
and  ||| S:32364 E:32378 ||| CC
380  ||| S:32378 E:32382 ||| CD
nm  ||| S:32382 E:32385 ||| NNS
[  ||| S:32385 E:32387 ||| -LRB-
42  ||| S:32387 E:32390 ||| CD
]  ||| S:32390 E:32392 ||| -RRB-
.  ||| S:32392 E:32422 ||| .
Measurement  ||| S:32422 E:32434 ||| NN
of  ||| S:32434 E:32437 ||| IN
AA  ||| S:32437 E:32440 ||| NN
release  ||| S:32440 E:32458 ||| NN
The  ||| S:32458 E:32462 ||| DT
protocol  ||| S:32462 E:32471 ||| NN
for  ||| S:32471 E:32475 ||| IN
determining  ||| S:32475 E:32487 ||| VBG
AA  ||| S:32487 E:32490 ||| NN
release  ||| S:32490 E:32498 ||| NN
is  ||| S:32498 E:32501 ||| VBZ
essentially  ||| S:32501 E:32523 ||| RB
as  ||| S:32523 E:32526 ||| RB
described  ||| S:32526 E:32536 ||| VBN
[  ||| S:32536 E:32538 ||| -LRB-
15  ||| S:32538 E:32541 ||| CD
21  ||| S:32541 E:32544 ||| CD
]  ||| S:32544 E:32546 ||| -RRB-
.  ||| S:32546 E:32548 ||| .
MDCK  ||| S:32548 E:32553 ||| NNP
cells  ||| S:32553 E:32559 ||| NNS
stably  ||| S:32559 E:32566 ||| VBP
expressing  ||| S:32566 E:32587 ||| VBG
EGFP-cPLA  ||| S:32587 E:32608 ||| JJ
2  ||| S:32608 E:32610 ||| CD
were  ||| S:32610 E:32615 ||| VBD
plated  ||| S:32615 E:32622 ||| VBN
in  ||| S:32622 E:32625 ||| IN
12-well  ||| S:32625 E:32633 ||| CD
plates  ||| S:32633 E:32640 ||| NN
at  ||| S:32640 E:32643 ||| IN
5  ||| S:32643 E:32645 ||| CD
×  ||| S:32645 E:32657 ||| CD
10  ||| S:32657 E:32660 ||| CD
3cells ||| S:32660 E:32666 ||| CD
/ ||| S:32666 E:32667 ||| CD
cm  ||| S:32667 E:32670 ||| CD
2and  ||| S:32670 E:32675 ||| CD
incubated  ||| S:32675 E:32685 ||| NN
in  ||| S:32685 E:32688 ||| IN
growth  ||| S:32688 E:32695 ||| NN
medium  ||| S:32695 E:32702 ||| NN
overnight ||| S:32702 E:32711 ||| RB
.  ||| S:32711 E:32723 ||| .
Cells  ||| S:32723 E:32729 ||| NNS
were  ||| S:32729 E:32734 ||| VBD
then  ||| S:32734 E:32739 ||| RB
washed  ||| S:32739 E:32746 ||| VBN
twice  ||| S:32746 E:32752 ||| RB
with  ||| S:32752 E:32757 ||| IN
serum-free  ||| S:32757 E:32768 ||| JJ
medium  ||| S:32768 E:32775 ||| NN
and  ||| S:32775 E:32789 ||| CC
incubated  ||| S:32789 E:32799 ||| NN
with  ||| S:32799 E:32804 ||| IN
0.25  ||| S:32804 E:32809 ||| CD
μCi  ||| S:32809 E:32813 ||| NNS
[  ||| S:32813 E:32815 ||| -LRB-
3H ||| S:32815 E:32817 ||| NNP
] ||| S:32817 E:32818 ||| -RRB-
-AA ||| S:32818 E:32821 ||| NNP
/ ||| S:32821 E:32822 ||| NNP
well  ||| S:32822 E:32827 ||| RB
in  ||| S:32827 E:32830 ||| IN
serum-free  ||| S:32830 E:32851 ||| JJ
medium  ||| S:32851 E:32858 ||| NN
overnight ||| S:32858 E:32867 ||| RB
.  ||| S:32867 E:32869 ||| .
U0126  ||| S:32869 E:32875 ||| NNP
or  ||| S:32875 E:32878 ||| CC
vehicle  ||| S:32878 E:32886 ||| NN
was  ||| S:32886 E:32890 ||| VBD
added  ||| S:32890 E:32896 ||| VBN
to  ||| S:32896 E:32899 ||| TO
each  ||| S:32899 E:32904 ||| DT
well  ||| S:32904 E:32919 ||| RB
and  ||| S:32919 E:32923 ||| CC
the  ||| S:32923 E:32927 ||| DT
cells  ||| S:32927 E:32933 ||| NNS
were  ||| S:32933 E:32938 ||| VBD
then  ||| S:32938 E:32943 ||| RB
incubated  ||| S:32943 E:32953 ||| VBN
for  ||| S:32953 E:32957 ||| IN
15  ||| S:32957 E:32960 ||| CD
min  ||| S:32960 E:32964 ||| NN
at  ||| S:32964 E:32967 ||| IN
37°C  ||| S:32967 E:32972 ||| CD
in  ||| S:32972 E:32985 ||| IN
5 ||| S:32985 E:32986 ||| CD
%  ||| S:32986 E:32988 ||| NN
CO  ||| S:32988 E:33002 ||| NNP
2  ||| S:33002 E:33004 ||| CD
.  ||| S:33004 E:33006 ||| .
Cells  ||| S:33006 E:33012 ||| NNS
were  ||| S:33012 E:33017 ||| VBD
washed  ||| S:33017 E:33024 ||| VBN
to  ||| S:33024 E:33027 ||| TO
remove  ||| S:33027 E:33044 ||| VB
unincorporated  ||| S:33044 E:33059 ||| NNS
[  ||| S:33059 E:33061 ||| -LRB-
3H ||| S:33061 E:33063 ||| NNP
] ||| S:33063 E:33064 ||| -RRB-
-AA  ||| S:33064 E:33068 ||| JJ
and  ||| S:33068 E:33072 ||| CC
then  ||| S:33072 E:33077 ||| RB
incubated  ||| S:33077 E:33087 ||| VBN
in  ||| S:33087 E:33090 ||| IN
HHBSS  ||| S:33090 E:33106 ||| NNP
supplemented  ||| S:33106 E:33119 ||| NN
with  ||| S:33119 E:33124 ||| IN
0.05 ||| S:33124 E:33128 ||| CD
%  ||| S:33128 E:33130 ||| NN
BSA  ||| S:33130 E:33134 ||| NN
with  ||| S:33134 E:33139 ||| IN
either  ||| S:33139 E:33146 ||| DT
U0126  ||| S:33146 E:33152 ||| NNP
or  ||| S:33152 E:33155 ||| CC
vehicle ||| S:33155 E:33162 ||| NN
.  ||| S:33162 E:33174 ||| .
Cells  ||| S:33174 E:33180 ||| NNS
were  ||| S:33180 E:33185 ||| VBD
stimulated  ||| S:33185 E:33196 ||| VBN
with  ||| S:33196 E:33201 ||| IN
the  ||| S:33201 E:33205 ||| DT
agonist  ||| S:33205 E:33213 ||| NN
of  ||| S:33213 E:33216 ||| IN
choice  ||| S:33216 E:33223 ||| NN
and  ||| S:33223 E:33227 ||| CC
the  ||| S:33227 E:33241 ||| DT
medium  ||| S:33241 E:33248 ||| NN
was  ||| S:33248 E:33252 ||| VBD
collected  ||| S:33252 E:33262 ||| VBN
at  ||| S:33262 E:33265 ||| IN
appropriate  ||| S:33265 E:33277 ||| JJ
time  ||| S:33277 E:33282 ||| NN
points ||| S:33282 E:33288 ||| NNS
.  ||| S:33288 E:33290 ||| .
The  ||| S:33290 E:33304 ||| DT
medium  ||| S:33304 E:33311 ||| NN
was  ||| S:33311 E:33315 ||| VBD
centrifuged  ||| S:33315 E:33327 ||| VBN
at  ||| S:33327 E:33330 ||| IN
500  ||| S:33330 E:33334 ||| CD
g  ||| S:33334 E:33336 ||| NN
for  ||| S:33336 E:33340 ||| IN
5  ||| S:33340 E:33342 ||| CD
min ||| S:33342 E:33345 ||| NN
,  ||| S:33345 E:33347 ||| ,
and  ||| S:33347 E:33351 ||| CC
the  ||| S:33351 E:33355 ||| DT
amount  ||| S:33355 E:33372 ||| NN
of  ||| S:33372 E:33375 ||| IN
radioactivity  ||| S:33375 E:33389 ||| NN
in  ||| S:33389 E:33392 ||| IN
the  ||| S:33392 E:33396 ||| DT
supernatant  ||| S:33396 E:33408 ||| NN
was  ||| S:33408 E:33412 ||| VBD
determined  ||| S:33412 E:33423 ||| VBN
by  ||| S:33423 E:33436 ||| IN
scintillation  ||| S:33436 E:33450 ||| JJ
counting ||| S:33450 E:33458 ||| NN
.  ||| S:33458 E:33460 ||| .
Cells  ||| S:33460 E:33466 ||| NNS
were  ||| S:33466 E:33471 ||| VBD
scraped  ||| S:33471 E:33479 ||| VBN
in  ||| S:33479 E:33482 ||| IN
0.5  ||| S:33482 E:33486 ||| CD
ml  ||| S:33486 E:33489 ||| CD
0.1 ||| S:33489 E:33492 ||| CD
%  ||| S:33492 E:33504 ||| NN
Triton  ||| S:33504 E:33511 ||| NNP
X-100  ||| S:33511 E:33517 ||| NNP
for  ||| S:33517 E:33521 ||| IN
determining  ||| S:33521 E:33533 ||| VBG
the  ||| S:33533 E:33537 ||| DT
total  ||| S:33537 E:33543 ||| JJ
cellular  ||| S:33543 E:33562 ||| JJ
radioactivity ||| S:33562 E:33575 ||| NN
.  ||| S:33575 E:33608 ||| .
Authors ||| S:33608 E:33615 ||| NNP
'  ||| S:33615 E:33617 ||| POS
contributions  ||| S:33617 E:33639 ||| NNS
JHE  ||| S:33639 E:33643 ||| VBP
carried  ||| S:33643 E:33651 ||| VBN
out  ||| S:33651 E:33655 ||| RP
the  ||| S:33655 E:33659 ||| DT
Ca  ||| S:33659 E:33662 ||| NNP
and  ||| S:33662 E:33666 ||| CC
FP  ||| S:33666 E:33669 ||| NNP
imaging  ||| S:33669 E:33677 ||| NN
studies ||| S:33677 E:33684 ||| NNS
,  ||| S:33684 E:33694 ||| ,
participated  ||| S:33694 E:33707 ||| VBD
in  ||| S:33707 E:33710 ||| IN
the  ||| S:33710 E:33714 ||| DT
design  ||| S:33714 E:33721 ||| NN
and  ||| S:33721 E:33725 ||| CC
coordination  ||| S:33725 E:33738 ||| NN
of  ||| S:33738 E:33741 ||| IN
the  ||| S:33741 E:33745 ||| DT
study ||| S:33745 E:33750 ||| NN
,  ||| S:33750 E:33760 ||| ,
and  ||| S:33760 E:33764 ||| CC
drafted  ||| S:33764 E:33772 ||| VBD
the  ||| S:33772 E:33776 ||| DT
manuscript ||| S:33776 E:33786 ||| NN
.  ||| S:33786 E:33788 ||| .
DJF  ||| S:33788 E:33792 ||| NNP
performed  ||| S:33792 E:33802 ||| VBD
the  ||| S:33802 E:33806 ||| DT
AA  ||| S:33806 E:33809 ||| NN
release  ||| S:33809 E:33825 ||| NN
and  ||| S:33825 E:33829 ||| CC
Western  ||| S:33829 E:33837 ||| JJ
blot  ||| S:33837 E:33842 ||| JJ
studies  ||| S:33842 E:33850 ||| NNS
and  ||| S:33850 E:33854 ||| CC
participated  ||| S:33854 E:33867 ||| VBD
in  ||| S:33867 E:33870 ||| IN
the  ||| S:33870 E:33874 ||| DT
design  ||| S:33874 E:33881 ||| NN
and  ||| S:33881 E:33893 ||| CC
coordination  ||| S:33893 E:33906 ||| NN
of  ||| S:33906 E:33909 ||| IN
the  ||| S:33909 E:33913 ||| DT
study ||| S:33913 E:33918 ||| NN
.  ||| S:33918 E:33920 ||| .
CCL  ||| S:33920 E:33924 ||| NNP
conceived  ||| S:33924 E:33934 ||| VBD
of  ||| S:33934 E:33937 ||| IN
the  ||| S:33937 E:33941 ||| DT
study ||| S:33941 E:33946 ||| NN
,  ||| S:33946 E:33956 ||| ,
participated  ||| S:33956 E:33969 ||| VBD
in  ||| S:33969 E:33972 ||| IN
its  ||| S:33972 E:33976 ||| PRP$
design  ||| S:33976 E:33983 ||| NN
and  ||| S:33983 E:33987 ||| CC
coordination ||| S:33987 E:33999 ||| NN
,  ||| S:33999 E:34001 ||| ,
and  ||| S:34001 E:34013 ||| CC
participated  ||| S:34013 E:34026 ||| VBD
in  ||| S:34026 E:34029 ||| IN
writing  ||| S:34029 E:34037 ||| VBG
the  ||| S:34037 E:34041 ||| DT
draft ||| S:34041 E:34046 ||| NN
.  ||| S:34046 E:34048 ||| .
All  ||| S:34048 E:34052 ||| DT
authors  ||| S:34052 E:34060 ||| NNS
read  ||| S:34060 E:34065 ||| VBP
and  ||| S:34065 E:34077 ||| CC
approved  ||| S:34077 E:34086 ||| VBD
the  ||| S:34086 E:34090 ||| DT
final  ||| S:34090 E:34096 ||| JJ
manuscript ||| S:34096 E:34106 ||| NN
.  ||| S:34106 E:34123 ||| .
